departament medicina memòria 2006
Post on 04-Jan-2017
227 Views
Preview:
TRANSCRIPT
1
Departament Medicina Memòria 2006
Docència, recerca i economia
2
Índex Docència Llicenciatura ...............................................................................................5 Doctorat.......................................................................................................7 Recerca Dermatologia...............................................................................................10 Malalties de la sang.....................................................................................12 Malalties de l'aparell càrdio-circulatori ......................................................14 Malalties de l'aparell digestiu ....................................................................16 Malalties de l'aparell respiratori..................................................................23 Malalties del sistema endocrí i de la nutrició..............................................32 Malalties del sistema excretor renal i genital masculí ................................35 Malalties del sistema nerviós ......................................................................36 Malalties infeccioses ..................................................................................40 Malalties reumatològiques i del sistema immune.......................................46 Medicina d'atenció primària........................................................................49 Oncologia clínica ........................................................................................53 Semiologia general i propedèutica..............................................................54 Hospitals col•laboradors .............................................................................56 Economia Funcionament ordinari ................................................................................61
3
Docència
4
5
Llicenciatura (Alumnes del curs 2006-2007) Assignatures troncals Crèdits Teoria Cr. Pràctiques Total Núm. Alumnes 3er. Curs Semiologia general i propedèutica....................................... 6 16 22 181 4rt. Curs Malalties de l'aparell càrdio-circulatori............................... 2,5 10,5 13 149 Malalties de l'aparell respiratori.......................................... 2,5 10,5 13 157 Malalties de la sang............................................................. 2,5 2 4,5 155 Oncologia clínica ................................................................ 2,5 2 4,5 156 Malalties de l'aparell digestiu ............................................. 2,5 10,5 13 152 Malalties del sistema nerviós............................................... 2,5 10,5 13 151 Malalties del sistema endocrí i de la nutrició...................... 4 3 7 158 5è. Curs Dermatologia...................................................................... 3 4 7 152 Medicina d'atenció primària............................................... 1 7 8 146 Malalties del sistema excretor renal i genital masculí........ 2,5 10,5 13 163 Malalties infeccioses ......................................................... 3,5 5 8,5 149 Malalties reumatològiques i del sistema immune ............. 2 3 5 140 Assignatures optatives Atenció multidisciplinària en el pacient vell .................... 4,5 4,5 60 Elements diagnòstics en medicina interna ....................... 4,5 4,5 49 Hematologia biològica. Diagnòstic de laboratori ............ 4,5 4,5 34 Indroducció al diagnòstic i tractament del malalt crític .. 6 6 48 Redacció mèdica ............................................................. 4,5 4,5 35 Síndrome d'immunodeficiència adquirida ...................... 4,5 4,5 35 Assignatures optatives com a treball pràctic Assistència clínica en zones urbanes socialment deprimides 15 15 6 Total................................................................................ 65,5 109,5 175 2.276
6
Hospitals i Centres de Salut i Atenció Primària associats al Departament de Medicina Hospital Clínic i Provincial de Barcelona Hospital Dos de Maig Hospital Esperit Sant Hospital General de Granollers Hospital General de l'Hospitalet Hospital Mútua de Terrassa CAPSE Rosselló EAP Casanovas CAPSE EAP Casc Antic EAP Dr Carles Ribas EAP El Clot EAP Gòtic EAP La Marina EAP La Mina EAP La Pau EAP Les Corts EAP Manso 2A Sant Antoni EAP Manso 2B Via Roma Manso EAP Poble Nou EAP Raval Nord Centre Dr. Lluis Sayé EAP Raval Sud
7
Doctorat Programa Biopatologia en Medicina: 2n any 36 alumnes Tesis aprovades: 17 Per publicacions 5 Format clàssic Total: 22 tesis aprovades Projectes de tesis d'alumnes amb suficiència investigadora inscrits pendents de presentar la tesi: Inscrits abans de 1998 Inscrits desprès de 1998 Total Alumnes de doctorat pla vell........ 63 25 88 Alumnes de doctorat pla 98.......... 28 28 Total...................... 116
8
9
Recerca
10
Dermatologia
Dermatologia - Publicacions 2006 Títol Autors Cita Original Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.
Gallardo F; Bellosillo B; Espinet B; Pujol RM; Estrach T; Servitje O; Romagosa V; Barranco C; Boluda S; Garcia M; Sole F; Ariza A; Serrano S
Human pathology; 2006 Jul; 37(7); p. 867-73
Dermoscopy in epidermodysplasia verruciformis.
Segura S; Carrera C; Ferrando J; Mascaro JM Jr; Palou J; Malvehy J; Puig S
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al]; 2006 Jan; 32(1); p. 103-6
Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature
Badeloe S; van Geel M; van Steensel MA; Bastida J; Ferrando J; Steijlen PM; Frank J; Poblete-Gutierrez P
Experimental dermatology; 2006 Sep; 15(9); p. 735-41
EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome
Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
European journal of cancer (Oxford, England : 1990); 2006 May; 42(8); p. 1014-30
Eosinophilic ulcer of the oral mucosa: another histological simulator of CD30+ lymphoproliferative disorders.
Segura S; Romero D; Mascaro JM Jr; Colomo L; Ferrando J; Estrach T
The British journal of dermatology; 2006 Aug; 155(2); p. 460-3
Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation
To-Figueras J; Badenas C; Carrera C; Munoz C; Mila M; Lecha M; Herrero C
Journal of inherited metabolic disease; 2006 Aug; 29(4); p. 580
Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.
To-Figueras J; Badenas C; Carrera C; Munoz C; Mila M; Lecha M; Herrero C
Journal of inherited metabolic disease; 2006 Aug; 29(4); p. 580
Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection
Lecha M; Badenas C; Puig S; Orfila J; Mila M; To-Figueras J; Munoz C; Mercader P; Herrero C
Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Sep; 20(8); p. 974-9
Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection
Lecha M; Badenas C; Puig S; Orfila J; Mila M; To-Figueras J; Munoz C; Mercader P; Herrero C
ournal of the European Academy of Dermatology and Venereology : JEADV; 2006 Sep; 20(8); p. 974-9
Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients
Herrero-Gonzalez JE; Brauns O; Egner R; Ronspeck W; Mascaro JM Jr; Jonkman MF; Zillikens D; Sitaru C
European journal of immunology; 2006 Apr; 36(4); p. 1039-48
11
National registry of Home Enteral Nutrition in 2003
Planas M; Lecha M; Garcia Luna PP; Pares RM; Chamorro J; Marti E; Bonada A; Irles JA; Boris MA; Cardona D; Zamarron I; Calanas AJ; Rodriguez A; Camarero E; Perez de la Cruz A; Mancha A; De Luis Roman D; Cos A; Luengo LM; Jimenez M; Bayo P; Goenaga MA
Nutricion hospitalaria : organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral; 2006 Jan-Feb; 21(1); p. 71-4
Results of radiotherapy in primary cutaneous lymphoma
Conill C; Navalpotro B; Lopez I; Estrach T Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico; 2006 Jun; 8(6); p. 430-4
The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Nov; 20(10); p. 1201-6
Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature.
Oranje AP; Devillers AC; Kunz B; Jones SL; DeRaeve L; Van Gysel D; de Waard-van der Spek FB; Grimalt R; Torrelo A; Stevens J; Harper J
Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Nov; 20(10); p. 1277-86
Cas Clínic An embossed tattoo Munoz C; Guilabert A; Mascaro JM Jr; Lopez-Lerma
I; Vilaplana J Clinical and experimental dermatology; 2006 Mar; 31(2); p. 309-10
Atypical pemphigus: discordance between clinicopathological findings and the antigenic profile in four cases
Herrero-Gonzalez JE; Mascaro JM Jr; Iranzo P; Herrero C
Journal of cutaneous pathology; 2006 Jul; 33(7); p. 502-7
Carta Autoantibodies from patients with BSLE inducing recruitment of leukocytes to the dermoepidermal junction and subepidermal splits in cryosections of human skin.
Herrero-Gonzalez JE; Mascaro JM Jr; Herrero C; Dilling A; Zillikens D; Sitaru C
Archives of dermatology; 2006 Nov; 142(11); p. 1513
Compound blue naevus: a potential simulator of melanoma
Carrera C; Ferrer B; Mascaro JM Jr; Palou J The British journal of dermatology; 2006 Jul; 155(1); p. 207-8
Erythema multiforme presenting as cholestatic acute hepatitis caused by Epstein-Barr virus
Carrera C; Alsina M; de Pablo IM; Iranzo P; Herrero C
Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Nov; 20(10); p. 1350-2
Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda.
Toll A; Celis R; Ozalla MD; Ercilla MG; Herrero C Acta dermato-venereologica; 2006; 86(3); p. 279-80
Not all images serve more than a thousand words
Moreno Romero JA; Guilabert Vidal A; Mascaro-Galy JM; Ferrando J
Medicina clinica; 2006 Oct 14; 127(14); p. 558
Where has all that hair gone? Cutrone M; Grimalt R Clinical and experimental dermatology; 2006 Jan; 31(1); p. 136-7
12
Malalties de la Sang
Malalties de la Sang - Publicacions 2006 Títol Autors Cita Original Anti-D alloimmunization after D-mismatchet allogeneic hematopoietic stem cell transplatation in patients with hematologic diseases
Cid J, Lozano M, Fernandez F, Carreras E, Pereira A, Mazzara R, Ordinas A
Transfusion 2006;46:169-69
Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin
Galan AM; van Heerde WL; Escolar G; Ordinas A; Sixma J; de Groot PG;
European journal of clinical investigation; 2006 Sep; 36(9); p. 633-9
Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions
Escolar G; Bozzo J; Maragall S Drugs of today (Barcelona, Spain : 1998); 2006 Apr; 42(4); p. 223-36
Assessment of platelet function in horses: ultrastructure, flow cytometry, and perfusion techniques
Segura D; Monreal L; Perez-Pujol S; Pino M; Ordinas A; Brugues R; White JG; Escolar G
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine; 2006 May-Jun; 20(3); p. 581-8
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients
Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B
Leukemia research; 2007 Feb; 31(2); p. 163-7
Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia
Cervantes F; Alvarez-Larran A; Hernandez-Boluda JC; Sureda A; Granell M; Vallansot R; Besses C; Montserrat E
British journal of haematology; 2006 Jul; 134(2); p. 184-6
Effects of etamsylate on equine platelets: In vitro and in vivo studies
Segura D; Monreal L; Perez-Pujol S; Alonso A; Diaz-Ricart M; Brugues R; Ordinas A; Escolar G
Veterinary journal (London, England : 1997); 2006 Aug 9;
Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity
Mosbah IB; Franco-Gou R; Abdennebi HB; Hernandez R; Escolar G; Saidane D; Rosello-Catafau J; Peralta C
Transplantation proceedings; 2006 Jun; 38(5); p. 1229-35
Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity
Hernandez MR; Tonda R; Pedreno J; Salas E; Arderiu G; Pino M; Serradell M; Escolar G
Journal of cardiovascular medicine (Hagerstown, Md); 2006 Dec; 7(12); p. 859-65
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Druker BJ; Guilhot F; O'Brien SG; Gathmann I; Kantarjian H; Gattermann N; Deininger MW; Silver RT; Goldman JM; Stone RM; Cervantes F; Hochhaus A; Powell BL; Gabrilove JL; Rousselot P; Reiffers J; Cornelissen JJ; Hughes T; Agis H; Fischer T; Verhoef G; Sh
The New England journal of medicine; 2006 Dec 7; 355(23); p. 2408
Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution
Cervantes F; Alvarez-Larran A; Arellano-Rodrigo E; Granell M; Domingo A; Montserrat E
Leukemia; 2006 Jan; 20(1); p. 55-60
Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version
Marin R; Goicoechea MA; Gorostidi M; Cases A; Diez J; Escolar G; Fernandez-Vega F; Palomar R; Rodrigo E; Martinez I; Segura J
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia; 2006; 26(1); p. 31-44
13
Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status
Arellano-Rodrigo E; Alvarez-Larran A; Reverter JC; Villamor N; Colomer D; Cervantes F
Haematologica; 2006 Feb; 91(2); p. 169-75
Rivaroxaban Escolar G, Villalta J, Casals F, Bozzo J, Serradell N, Bolós J
Drug Future 2006; 31(6):484-493
Serotonergic mechanisms: a potential link between affective disorders and cardiovascular risk.
Escolar G; Diaz-Ricart M; Gomez-Gil E; Serra M; Gasto C; Bozzo J; Galan AM
Timely topics in medicine Cardiovascular diseases; 2006 Feb 1; 10; p. E3
Serotoninergic mechanisms: a potential link between affective disorders and cardiovascular risk
G Escolar, M Díaz-Ricart, E Gómez-Gil, M Serra, C Gastó, J Bozzo, AM Galán
Timely Top Med Cardiovasc Dis : 10:E3; 2006
Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia
Costa D; Carrio A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camos M; Cervantes F; Campo E
Cancer genetics and cytogenetics; 2006 Apr 1; 166(1); p. 89-93
Revisió Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Baccarani M; Saglio G; Goldman J; Hochhaus A; Simonsson B; Appelbaum F; Apperley J; Cervantes F; Cortes J; Deininger M; Gratwohl A; Guilhot F; Horowitz M; Hughes T; Kantarjian H; Larson R; Niederwieser D; Silver R; Hehlmann R
Blood; 2006 Sep 15; 108(6); p. 1809-20
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)
Tefferi A; Barosi G; Mesa RA; Cervantes F; Deeg HJ; Reilly JT; Verstovsek S; Dupriez B; Silver RT; Odenike O; Cortes J; Wadleigh M; Solberg LA Jr; Camoriano JK; Gisslinger H; Noel P; Thiele J; Vardiman JW; Hoffman R; Cross NC; Gilliland DG; Kantarjian H
Blood; 2006 Sep 1; 108(5); p. 1497-503
Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options
Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A Best practice & research Clinical haematology; 2006; 19(3); p. 495-517
Malalties de la sang - Projectes finançats 2006
Investigador Principal Referència Ajut Entitat Nom Projecte Import Durada Cervantes F U-2006-
FS060038-O
FIS Estudio de la relación entre la presencia de polimorfismos genéticos en los genes MDR1, hOCT1 y AGP1 y la respuesta la tratamiento con imatinib en los pacientes con leucemia mieloide crónica
62.900
2006-2008
Escolar G PB-B1-10007 Ag. de Gestió d'Ajuts Universitaris i de Recerca
Cooperación del colágeno, factor tisular depositado y desencriptado en la formación y propagación del trombo bajo condiciones de flujo
63.800 2006-2008
Escolar G PTR1995-0890-OP
Ministerio Ciencia y Tecnología
Desarrollo y evaluación toxicológica de prototipos de sustitivos sintéticos para los concentrados de plaquetas
81.000 2003-2006
Escolar G SAF2003-05780 Ministerio de Ciencia y Tecnología
Cooperación del colágeno, factor tisular depositado y desencriptado en la formación y propagación del trombo bajo condiciones de flujo
133.100 2003-2006
Escolar G SAF2006-08003 Ministerio Educación y Ciencia
Factor tisular circulante y asociado a las plaquetas: papel en la formación de trombos oclusivos sobre lesiones arteriales, implicaciones fisiológicas, clínicas y terapéuticas
137.000 2006-2009
Ordinas A 2005RG009532 Ag. de Gestió d'Ajuts Universitaris i de Recerca
Grup de fisiopatologia, d'hemostàsia i trombosi 31.600 2005.2008
14
Malalties de l'Aparell Càrdio-circulatori
Malalties Aparell Càrdio-circulatori - Publicacions 2006 Títol Autors Cita Original A Practical Approach With Outcome for the Prognostic Assessment of Non-ST-Segment Elevation Chest Pain and Normal Troponin
Sanchis J; Bodi V; Nunez J; Bosch MJ; Bertomeu-Gonzalez V; Consuegra L; Santas E; Gomez C; Bosch X; Chorro FJ; Llacer A
The American journal of cardiology; 2007 Mar 15; 99(6); p. 797-801
Anodal capture in cardiac resynchronization therapy implications for device programming
Tamborero D; Mont L; Alanis R; Berruezo A; Tolosana JM; Sitges M; Vidal B; Brugada J
Pacing and clinical electrophysiology : PACE; 2006 Sep; 29(9); p. 940-5
Clinical and echocardiographic follow-up of patients with hypertrophic obstructive cardiomyopathy treated by percutaneous septal ablation
Delgado V; Sitges M; Andrea R; Rivera S; Masotti M; Francino A; Azqueta M; Pare C; Betriu A
Revista espanola de cardiologia; 2006 Nov; 59(11); p. 1123-30
Complications of Native andProsthetic Valve Infective Endocarditis: Update in 2006
Anguera I; Del Rio A; Moreno A; Pare C; Mestres CA; Miro JM
Current infectious disease reports; 2006 Jun; 8(4); p. 280-8
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome
Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
Circulation; 2006 Nov 7; 114(19); p. 2026-33
Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome
Brugada R; Brugada P; Brugada J Journal of electrocardiology; 2006 Oct; 39(4 Suppl); p. S115-8
European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance
Auricchio A; Gropp M; Ludgate S; Vardas P; Brugada J; Priori SG
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology; 2006 May; 8(5); p. 313-22
Familial pseudo-Wolff-Parkinson-White syndrome
Sternick EB; Oliva A; Magalhaes LP; Gerken LM; Hong K; Santana O; Brugada P; Brugada J; Brugada R
Journal of cardiovascular electrophysiology; 2006 Jul; 17(7); p. 724-32
Hemodialysis prospective multicentric quality study
Parra E; Ramos R; Betriu A; Paniagua J; Belart M; Martin F; Martinez T
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia; 2006; 26(6); p. 688-94
Hemodialysis prospective multicentric quality study
Parra E; Ramos R; Betriu A; Paniagua J; Belart M; Martin F; Martinez T
Nefrologia; 2006; 26(6); p. 688-94
Hemolysis in mechanical bileaflet prostheses: experience with the Bicarbon valve
Josa M; Castella M; Pare C; Bedini JL; Cartana R; Mestres CA; Pomar JL; Mulet J
The Annals of thoracic surgery; 2006 Apr; 81(4); p. 1291-6
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial
Chacko M; Lincoff AM; Wolski KE; Cohen DJ; Bittl JA; Lansky AJ; Tsuchiya Y; Betriu A; Yen MH; Chew DP; Cho L; Topol EJ
American heart journal; 2006 May; 151(5); p. 1032.e1-7
15
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial
Kaul P; Chang WC; Lincoff AM; Aylward P; Betriu A; Bode C; Califf RM; Ohman EM; Guetta V; Steg PG; Van de Werf F; Armstrong PW
European heart journal; 2006 May; 27(10); p. 1198-206
Performance assessment of an emergency department chest pain unit
Bragulat E; Lopez B; Miro O; Coll-Vinent B; Jimenez S; Aparicio MJ; Heras M; Bosch X; Valls V; Sanchez M
Revista espanola de cardiologia; 2007 Mar; 60(3); p. 276-84
Periannular complications in infective endocarditis involving native aortic valves
Anguera I; Miro JM; Evangelista A; Cabell CH; San Roman JA; Vilacosta I; Almirante B; Ripoll T; Farinas MC; Anguita M; Navas E; Gonzalez-Juanatey C; Garcia-Bolao I; Munoz P; de Alarcon A; Sarria C; Rufi G; Miralles F; Pare C; Fowler VG Jr; Mestres CA; de
The American journal of cardiology; 2006 Nov 1; 98(9); p. 1254-60
Periannular complications in infective endocarditis involving prosthetic aortic valves
Anguera I; Miro JM; San Roman JA; de Alarcon A; Anguita M; Almirante B; Evangelista A; Cabell CH; Vilacosta I; Ripoll T; Munoz P; Navas E; Gonzalez-Juanatey C; Sarria C; Garcia-Bolao I; Farinas MC; Rufi G; Miralles F; Pare C; Fowler VG Jr; Mestres CA; de
The American journal of cardiology; 2006 Nov 1; 98(9); p. 1261-8
Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain
Sanchis J; Bodi V; Nunez J; Bertomeu V; Consuegra L; Bosch MJ; Gomez C; Bosch X; Chorro FJ; Llacer A
The American journal of cardiology; 2006 Oct 1; 98(7); p. 885-9
Recurrent syncope: an unusual presentation of Brugada syndrome
Benito B; Brugada J Nature clinical practice Cardiovascular medicine; 2006 Oct; 3(10); p. 573-7; quiz following 577
Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling
Vidal B; Sitges M; Marigliano A; Diaz-Infante E; Azqueta M; Tamborero D; Macias A; Roig E; Brugada J; Pare C; Mont L
The American journal of cardiology; 2006 Mar 15; 97(6); p. 876-81
Specialized care program for end-stage heart failure patients. Initial experience in a heart failure unit
Roig E; Perez-Villa F; Cuppoletti A; Castillo M; Hernandez N; Morales M; Betriu A
Revista espanola de cardiologia; 2006 Feb; 59(2); p. 109-16
Sport practice and the risk of lone atrial fibrillation: a case-control study
Elosua R; Arquer A; Mont L; Sambola A; Molina L; Garcia-Moran E; Brugada J; Marrugat J
International journal of cardiology; 2006 Apr 14; 108(3); p. 332-7
Transient endothelial dysfunction is present shortly after cardioversion in patients with lone atrial fibrillation
Coll-Vinent B; Monteagudo J; Miro O; Luis Marin J; Nava S; Scalise A; Sanchez M; Bragulat E; Sitges M; Brugada J; Mont L
Thrombosis research; 2006; 117(3); p. 235-40
Cas Clínic Epicardial ablation of syncopal ventricular tachycardia. Utility of the electrocardiogram
Berruezo A; Cano L; Mont L; Brugada J Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology; 2006 May; 8(5); p. 338-40
Images in cardiology. Left ventricular pseudoaneurysm complicating acute myocardial infarction: improved diagnosis by real time three dimensional echocardiography
Freixa X; Sitges M; Pare C Heart (British Cardiac Society); 2006 Feb; 92(2); p. 154
16
Malalties de l'Aparell Digestiu
Malalties de l'Aparell Digestiu - Publicacions 2006 Títol Autors Cita Originals A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6); p. 1758-67
Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease
Garcia Rodriguez LA; Ruigomez A; Panes J Gastroenterology; 2006 May; 130(6); p. 1588-94
Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.
Fernandez J; Escorsell A; Zabalza M; Felipe V; Navasa M; Mas A; Lacy AM; Gines P; Arroyo V
Hepatology (Baltimore, Md); 2006 Nov; 44(5); p. 1288-95
Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice
Arenas M; Gil F; Gironella M; Hernandez V; Jorcano S; Biete A; Pique JM; Panes J
International journal of radiation oncology, biology, physics; 2006 Oct 1; 66(2); p. 560-7
Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice
Justicia C; Martin A; Rojas S; Gironella M; Cervera A; Panes J; Chamorro A; Planas AM
ournal of cerebral blood flow and metabolism; 2006 Mar; 26(3); p. 421-32
Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome
Esteva-Font C; Baccaro ME; Fernandez-Llama P; Sans L; Guevara M; Ars E; Jimenez W; Arroyo V; Ballarin JA; Gines P
Hepatology (Baltimore, Md); 2006 Dec; 44(6); p. 1555-63
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
Hernandez-Guerra M; Garcia-Pagan JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
Hepatology (Baltimore, Md); 2006 Mar; 43(3); p. 485-91
Caroli's disease Bruguera M; Ros E Gastroenterologia y hepatologia; 2006 Oct; 29(8); p. 462-7
Cation-pi Interactions and oxidative effects on Cu+ and Cu2+ binding to Phe, Tyr, Trp, and His amino acids in the gas phase. Insights from first-principles calculations
Rimola A; Rodriguez-Santiago L; Sodupe M The journal of physical chemistry B, Condensed matter, materials, surfaces, interfaces & biophysical; 2006 Nov 30; 110(47); p. 24189-99
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome
Ramos-Casals M; Sanchez-Tapias JM; Pares A; Forns X; Brito-Zeron P; Nardi N; Vazquez P; Velez D; Arias I; Bove A; Plaza J; Rodes J; Font J
The Journal of rheumatology; 2006 Aug; 33(8); p. 1593-9
Clinical practice guideline for irritable bowel syndrome
Tort S; Balboa A; Marzo M; Carrillo R; Minguez M; Valdeperez J; Alonso-Coello P; Mascort JJ; Ferrandiz J; Bonfill X; Pique JM; Mearin F
Gastroenterologia y hepatologia; 2006 Oct; 29(8); p. 467-521
Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease
Cabriada JL; Domenech E; Gomollon F; Gonzalez-Carro P; Gonzalez-Lara V; Hinojosa J; Jimenez-Lopez CE; Nos P; Obrador A; Panes J; Saro C; Varea V; Lafuente R; Guilera M
Gastroenterologia y hepatologia; 2006 Feb; 29(2); p. 85-92
Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency
Castells A; Paya A; Alenda C; Rodriguez-Moranta F; Agrelo R; Andreu M; Pinol V; Castellvi-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Salo J; Medina E; Naranjo A; Esteller M; Pique JM
Clinical cancer research : an official journal of the American Association for Cancer Research; 2006 Mar 15; 12(6); p. 1686-92
17
Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts
Figueras J; Prieto M; Bernardos A; Rimola A; Suarez F; de Urbina JO; Cuervas-Mons V; Mata Mde L
Transplant international : official journal of the European Society for Organ Transplantation; 2006 Aug; 19(8); p. 641-8
Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis
Lederer SL; Walters KA; Proll S; Paeper B; Robinzon S; Boix L; Fausto N; Bruix J; Katze MG
Virology journal; 2006 Nov 22; 3; p. 98
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA
Gonzalez-Periz A; Planaguma A; Gronert K; Miquel R; Lopez-Parra M; Titos E; Horrillo R; Ferre N; Deulofeu R; Arroyo V; Rodes J; Claria J
The FASEB journal; 2006 Dec; 20(14); p. 2537-9
Does silica surface catalyse peptide bond formation? New insights from first-principles calculations
Rimola A; Tosoni S; Sodupe M; Ugliengo P Chemphyschem : a European journal of chemical physics and physical chemistry; 2006 Jan 16; 7(1); p. 157-63
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation
Kremer-Tal S; Narla G; Chen Y; Hod E; Difeo A; Yea S; Lee JS; Schwartz M; Thung SN; Fiel IM; Banck M; Zimran E; Thorgeirsson SS; Mazzaferro V; Bruix J; Martignetti JA; Llovet JM; Friedman SL
Journal of hepatology; 2006 Nov 27
Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension
Andreu V; Garcia-Pagan JC; Lionetti R; Piera C; Abraldes JG; Bosch J
Journal of hepatology; 2006 Jun; 44(6); p. 1040-5
Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension
Luca A; Miraglia R; Caruso S; Milazzo M; Gidelli B; Bosch J
Liver transplantation; 2006 Aug; 12(8); p. 1237-43
Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact
Gines A; Pellise M; Fernandez-Esparrach G; Soria MT; Mata A; Membrillo A; Martinez-Palli G; Sole MM; Llach J; Bordas JM; Pique JM
The American journal of gastroenterology; 2006 Jan; 101(1); p. 64-9
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid
Pares A; Caballeria L; Rodes J Gastroenterology; 2006 Mar; 130(3); p. 715-20
Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there
Llovet JM; Schwartz M; Fuster J; Bruix J Seminars in liver disease; 2006 Aug; 26(3); p. 248-53
Gene expression profiling of renal dysfunction in rats with experimental cirrhosis
Lopez-Parra M; Telleria N; Titos E; Planaguma A; Gonzalez-Periz A; Arroyo V; Rodes J; Claria J
Journal of hepatology; 2006 Aug; 45(2); p. 221-9
Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats
Angermayr B; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J; Fernandez M
Journal of hepatology; 2006 Jun; 44(6); p. 1033-9
Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review
D'Amico G; Garcia-Pagan JC, Luca A; Bosch J Gastroenterology; 2006;131:1611-24
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
Blasco A; Forns X; Carrion JA; Garcia-Pagan JC; Gilabert R; Rimola A; Miquel R; Bruguera M; Garcia-Valdecasas JC; Bosch J; Navasa M
Hepatology (Baltimore, Md); 2006 Mar; 43(3); p. 492-9
18
Hepatitis B vaccine and multiple sclerosis: an unproved association
Salleras L; Bruguera M; Prat A Medicina clinica; 2006 Apr 22; 126(15); p. 581-8
Hepatocarcinoma and HCV Forner A; Varela M; Bruix J Gastroenterologia y hepatologia; 2006 Oct; 29 Suppl 2; p. 196-9
Hepatocellular carcinoma in the setting of liver transplantation
Varela M; Sanchez W; Bruix J; Gores GJ Liver transplantation; 2006 Jul; 12(7); p. 1028-36
How ischaemic preconditioning protects small liver grafts
Franco-Gou R; Rosello-Catafau J; Casillas-Ramirez A; Massip-Salcedo M; Rimola A; Calvo N; Bartrons R; Peralta C
The Journal of pathology; 2006 Jan; 208(1); p. 62-73
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation
Londono MC; Guevara M; Rimola A; Navasa M; Taura P; Mas A; Garcia-Valdecasas JC; Arroyo V; Gines P
Gastroenterology; 2006 Apr; 130(4); p. 1135-43
Hyponatremia in cirrhosis: clinical features and management
Martin-Llahi M; Guevara M; Gines P Gastroenterologie clinique et biologique; 2006 Oct; 30(10); p. 1144-51
Hyponatremia in cirrhosis: Results of a patient population survey
Angeli P; Wong F; Watson H; Gines P Hepatology (Baltimore, Md); 2006 Dec; 44(6); p. 1535-42
Impact of upper digestive symptoms in patients with irritable bowel syndrome
Balboa A; Mearin F; Badia X; Benavent J; Caballero AM; Dominguez-Munoz JE; Garrigues V; Pique JM; Roset M; Cucala M; Figueras M
European journal of gastroenterology & hepatology; 2006 Dec; 18(12); p. 1271-7
Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats
Fernandez-Varo G; Morales-Ruiz M; Ros J; Tugues S; Munoz-Luque J; Casals G; Arroyo V; Rodes J; Jimenez W;
Journal of hepatology; 2007 Mar; 46(3); p. 440-446
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis
Turnes J; Hernandez-Guerra M; Abraldes JG; Bellot P; Oliva R; Garcia-Pagan JC; Bosch J
Hepatology (Baltimore, Md); 2006 Jan; 43(1); p. 34-41
Interaction of glycine with isolated hydroxyl groups at the silica surface: first principles B3LYP periodic simulation
Rimola A; Sodupe M; Tosoni S; Civalleri B; Ugliengo P
Langmuir : the ACS journal of surfaces and colloids; 2006 Jul 18; 22(15); p. 6593-604
Irritable intestine syndrome: a disease with a high social, economic, and health-service load
Pique JM; Lanas A Atencion primaria / Sociedad Espanola de Medicina de Familia y Comunitaria; 2006 Jun 30; 38(2); p. 69-71
Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?
Vilana R; Bianchi L; Varela M; Nicolau C; Sanchez M; Ayuso C; Garcia M; Sala M; Llovet JM; Bruix J; Bru C
European radiology; 2006 Nov; 16(11); p. 2454-62
Ischemia-reperfusion syndrome associated with liver transplantation: an update
Casillas-Ramirez A; Mosbah IB; Franco-Gou R; Rimola A; Rosello-Catafau J; Peralta C
Gastroenterologia y hepatologia; 2006 May; 29(5); p. 306-13
Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis
Angulo S; Llopis M; Antolin M; Gironella M; Sans M; Malagelada JR; Pique JM; Guarner F; Panes J
American journal of physiology Gastrointestinal and liver physiology; 2006 Dec; 291(6); p. G1155-62
Life events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission
Vidal A; Gomez-Gil E; Sans M; Portella MJ; Salamero M; Pique JM; Panes J
The American journal of gastroenterology; 2006 Apr; 101(4); p. 775-81
Management of ascites and hepatic hydrothorax
Cardenas A; Arroyo V Best practice & research Clinical gastroenterology; 2007; 21(1); p. 55-75
19
Management of gut ischemia Pique JM ndian journal of gastroenterology; 2006 Nov; 25 Suppl; p. S39-42
Microbiologic features and outcome of pneumonia in transplanted patients
Cervera C; Agusti C; Angeles Marcos M; Pumarola T; Cofan F; Navasa M; Perez-Villa F; Torres A; Moreno A
Diagnostic microbiology and infectious disease; 2006 May; 55(1); p. 47-54
Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy
Minguez B; Garcia-Pagan JC; Bosch J; Turnes J; Alonso J; Rovira A; Cordoba J
Hepatology (Baltimore, Md); 2006 Apr; 43(4); p. 707-14
Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells
Sancho-Bru P; Bataller R; Colmenero J; Gasull X; Moreno M; Arroyo V; Brenner DA; Gines P
American journal of physiology Gastrointestinal and liver physiology; 2006 Nov; 291(5); p. G877-84
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage
Fernandez J; Ruiz del Arbol L; Gomez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4); p. 1049-56; quiz 1285
Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis
Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
The American journal of gastroenterology; 2006 Mar; 101(3); p. 506-12
Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial
Rodriguez-Moranta F; Salo J; Arcusa A; Boadas J; Pinol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Pique JM; Castells A
Journal of clinical oncology; 2006 Jan 20; 24(3); p. 386-93
Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients
Mearin F; Badia X; Balboa A; Benavent J; Caballero AM; Dominguez-Munoz E; Garrigues V; Pique JM; Roset M; Cucala M; Figueras M
Alimentary pharmacology & therapeutics; 2006 Mar 15; 23(6); p. 815-26
Prevalence of gastro-oesophageal reflux disease in Spain and associated factors
Ponce J; Vegazo O; Beltran B; Jimenez J; Zapardiel J; Calle D; Pique JM
Alimentary pharmacology & therapeutics; 2006 Jan 1; 23(1); p. 175-84
Prevention of viral hepatitis Bruguera M Enfermedades infecciosas y microbiologia clinica; 2006 Dec; 24(10); p. 649-56
Prospective assessment of the role of antibiotic prophylaxis in ERCP
Llach J; Bordas JM; Almela M; Pellise M; Mata A; Soria M; Fernandez-Esparrach G; Gines A; Elizalde JI; Feu F; Pique JM
Hepato-gastroenterology; 2006 Jul-Aug; 53(70); p. 540-2
Purification of recombinant histidine-tag streptolysin O using immobilized metal affinity expanded bed adsorption (IMA-EBA)
Camprubi S; Bruguera M; Canalias F International journal of biological macromolecules; 2006 Mar 30; 38(2); p. 134-9
Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells
Bertolani C; Sancho-Bru P; Failli P; Bataller R; Aleffi S; DeFranco R; Mazzinghi B; Romagnani P; Milani S; Gines P; Colmenero J; Parola M; Gelmini S; Tarquini R; Laffi G; Pinzani M; Marra F
The American journal of pathology; 2006 Dec; 169(6); p. 2042-53
Risk assessment in relatives of gastric cancer patients: hyperproliferation, genetics, and Helicobacter pylori infection
Ignasi Elizalde J; Pique JM European journal of gastroenterology & hepatology; 2006 Aug; 18(8); p. 877-9
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
Lanas A; Garcia-Rodriguez LA; Arroyo MT; Gomollon F; Feu F; Gonzalez-Perez A; Zapata E; Bastida G; Rodrigo L; Santolaria S; Guell M; de Argila CM; Quintero E; Borda F; Pique JM
Gut; 2006 Dec; 55(12); p. 1731-8
20
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil
Brunet M; Cirera I; Martorell J; Vidal E; Millan O; Jimenez O; Rojo I; Londono MC; Rimola A
Transplantation; 2006 Feb 27; 81(4); p. 541-6
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation
Martinez-Palli G; Gomez FP; Barbera JA; Navasa M; Roca J; Rodriguez-Roisin R; Burgos F; Gistau C
World journal of gastroenterology : WJG; 2006 Sep 28; 12(36); p. 5878-83
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome
Hernandez-Guerra M; Lopez E; Bellot P; Piera C; Turnes J; Abraldes JG; Bosch J; Garcia-Pagan JC
Hepatology (Baltimore, Md); 2006 Jan; 43(1); p. 27-33
The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis
Matei V; Rodriguez-Vilarrupla A; Deulofeu R; Colomer D; Fernandez M; Bosch J; Garcia-Pagan JC
Hepatology (Baltimore, Md); 2006 Jul; 44(1); p. 44-52
The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
Journal of the European Academy of Dermatology and Venereology : JEADV; 2006 Nov; 20(10); p. 1201-6
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease
Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Pique JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
Journal of immunology (Baltimore, Md : 1950); 2006 Feb 15; 176(4); p. 2617-24
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation
Carrion JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X
Liver transplantation; 2006 Dec; 12(12); p. 1791-8
Wilson's disease Bruguera M Gastroenterologia y hepatologia; 2006 Jan; 29(1); p. 29-33
Revisió Cavernous hemangioma Bruguera M Gastroenterologia y hepatologia; 2006
Aug-Sep; 29(7); p. 428-30 Hepatitis C in Spain Bruguera M; Forns X Medicina clinica; 2006 Jun 17; 127(3);
p. 113-7 Hepatorenal syndrome Cardenas A; Gines P Clinics in liver disease; 2006 May;
10(2); p. 371-85, ix-x Hyponatremia in cirrhosis: clinical features and management
Martin-Llahi; Guevara M, GInez P Gastroenterol Clin Biol 2006;30:1144-51
Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?
Miro JM; Laguno M; Moreno A; Rimola A Journal of hepatology; 2006; 44(1 Suppl); p. S140-5
Measurement of portal pressure and its role in the management of chronic liver disease
Bosch J; Garcia-Pagan JC; Berzigotti A; Abraldes JG
Seminars in liver disease; 2006 Nov; 26(4); p. 348-62
New aspects of diagnosis and therapy of hepatocellular carcinoma
Bruix J; Hessheimer AJ; Forner A; Boix L; Vilana R; Llovet JM
Oncogene; 2006 Jun 26; 25(27); p. 3848-56
New treatments of hepatorenal syndrome
Arroyo V; Terra C; Gines P Seminars in liver disease; 2006 Aug; 26(3); p. 254-64
Predictions from a hard liver Bosch J Journal of hepatology; 2006 Aug; 45(2); p. 230-5
21
Therapy insight: Management of hepatorenal syndrome
Cardenas A; Gines P Nature clinical practice Gastroenterology & hepatology; 2006 Jun; 3(6); p. 338-48
Treatment of hepatocellular carcinoma
Forner A; Hessheimer AJ; Isabel Real M; Bruix J Critical reviews in oncology/hematology; 2006 Nov; 60(2); p. 89-98
Cas Clínic Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome
Mundo J; Peris P; Monegal A; Navasa M; Cervera R; Guaniabens N
Lupus; 2006; 15(5); p. 304-7
Editorial A brief dictionary of eponyms used in gastroenterology
Bruguera M Gastroenterologia y hepatologia; 2006 Mar; 29(3); p. 125-30
Diagnosis and staging of hepatocellular carcinoma prior to transplantation: expertise or failure
Varela M; Forner A; Bruix J Liver transplantation; 2006 Oct; 12(10); p. 1445-7
Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients
Varela M; Bruix J Journal of hepatology; 2006 Jan; 44(1); p. 8-10
Presentation Arroyo V Gastroenterologia y hepatologia; 2006 Oct; 29 Suppl 2; p. 1
Unmet needs in the approach to irritable bowel syndrome
Pique JM; Lanas A Gastroenterologia y hepatologia; 2006 Jun-Jul; 29(6); p. 349-51
Carta Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route
Conget I; Piquer S; Julia M; Gomis R; Esmatjes E; Garcia-Pagan JC; Bosch J; Gilabert R; Ricart MJ; Fernandez-Cruz L; Manyalich M
Transplantation; 2006 Apr 27; 81(8); p. 1220-1
Is oral ciclosporin necessary to switch from i.v. to thiopurines?
Domenech E; Gomollon F; Obrador A; Panes J; Gassull MA
Alimentary pharmacology & therapeutics; 2006 Feb 15; 23(4); 555-6; author reply 556-7
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section
Mallolas J; Gatell JM; Bruguera M AIDS (London, England); 2006 Aug 22; 20(13); p. 1785
Capítul llibre Ascites and spontaneous bacterial peritonitis
Cárdenas A, Ginès P, Rodés J En: Therapy of Digestive Disorders 2nd Ed. Wolfe MM, Davis GL, Farraye F, Giannella RA, Malagelada JR, Steer ML. Eds. Saunders 2006, 607-18
Complications of Cirrhosis: Ascites, Hyponatremia, Hepatorenal Syndrome, and Spontaneous Bacterial Peritonitis
Cárdenas A, Ginès P, Arroyo V, Rodés J In: Comprehensive Clinical Hepatology, 2nd Ed. O’Grady J and Bacon B Eds. Mosby. 2006, 153-168.
Hemorragia digestiva por hipertensión portal
García-Pagán JC, Bosch J. En: Problemas comunes en la práctica clínica. Gastroenterología y Hepatología. Tomo II (MA. Montoro)Jarpyo Editoreas SA Madrid 2006- ISBN (2 tomos):84-96549-26-7.
Hepatocellular Carcinoma J. Maurel , J. Bruix En : Hematology-Oncology Therapy. Editor: Michael M. Boyiadzis, Peter F. Lebowitz, James N. Frame, Tito Fojo.2006: 179-182.
22
Hepatocellular Carcinoma J. Bruix, C. Brú, JM. Llovet En: Hepatology, a textbook of liver disease. Editor: Tomas D. Boyer, Teresa L. Wright, Michael P. Manns. Zakim and Boyer’s 2006. 1109 – 1131
Hepatoma M. Varela, M. Sala, J. Bruix En: Medical care of the Liver Transplant Patient. Editor: Paul G. Killenberg & Pierre-Alain Clavien, 2006: 119-138
Hepatorenal Syndrome Arroyo V, Ginès P, Terra C, Torre A En: Clinical critical care medicine. Eds: Albert RK, Slutsky A, Ranieri M, Takala J, Torres A. Mosby Elsevier. 489-96
Hepatorenal syndrome: current concepts
Cardenas A, Ginès P Eds de Franchis R. Portal Hypertension IV- Procc. Of the Fourth Baveno 2005. Blackwell. Oxford, 2006, 201-16.
Hyponatremia: a risk factor of hepatic encephalopathy in cirrosis
Guevara M, Ginès P EN: Hepatic encephalopathy and nitrogen metabolism. Eds. Häussinger D, Kirscheis G, Schlies F. Springer 2006, 458-66.
Prólogo J. Bruix En: Pathology of Hepatocellular Carcinoma: Editor: Masamichi Kokjiro. 2006
Renal Dysfunction in Cirrhosis: Pathophysiology on Clinical Features
Arroyo V, Ginès P, Guevara M, Rodés J En: Zakim D, Boyer J (eds) 5th Edition. Hepatology. A text book of liver diseases. 2006, 417-52.
Treatment of the acute bleeding episode
Laine L, Planas R, Nevens F, Bañares R, Patch D, Bosch J
En: Portal Hypertension IV. Procedings of the Fourth Baveno International COnsensus Workshop. Ed: Roberto de Franchis. Ed: Blackwell Publishing Ltd. Oxford, 2006. ISBN-13: 978-1-4051-3940-3. IBC-10:1-4051-3940-4
Malalties de l'Aparell Digestiu - Projectes Finançats 2006 Inv. Principal Ref. Ajut Entitat Nom Projecte Import € Durada Arroyo V 00071 Agència de Gestió
d’Ajuts Universitaris i de Recerca (AGAUR) - SGR
Grup de Recerca en Hepatología Clínica 50.600 ???
Bosch J
PI 04/0655
Fondo Investigacion Sanitaria
Hemodinámica hepática e hipertensión portal. Nuevos desarrollos en la fisiopatología, evaluación no invasiva y tratamiento
174.225
2004-2007
Bosch J
C03/02
Instituto de Salud Carlos III
Red Nacional de Investigación en Hepatología y Gastroenterología. Redes Temáticas de Investigación Cooperativa
1.463.126
2003-2006
Bosch J Instituto de Salud Carlos III
CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD). Área de hipertensión portal y mecanismos de transición a cirrosis (Área 1)
5.120.000 2006
Bosch J PI05/1285 FIS Fisiopatología y nuevas formas de tratamiento de las enfermedades hepáticas, gastroenterológicas y pancreáticas
232.050 2005-2006
Bosch J PI06/0623 FIS Disfunción endotelial y actividad enos en la cirrosis. Mecanismo, significación y nuevas aplicaciones terapéuticas
289.795 2006
23
Malalties de l'Aparell Respiratori
Malalties de l'Aparell Respiratori - Publicacions 2006 Títol Autors Cita Original A new BAL fluid instillation and aspiration technique: a multicenter randomized study
Rosell A; Xaubet A; Agusti C; Castella J; Puzo C; Curull V; de Gracia J
Respiratory medicine; 2006 Mar; 100(3); p. 529-35
A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps.
Benitez P; Alobid I; de Haro J; Berenguer J; Bernal-Sprekelsen M; Pujols L; Picado C; Mullol J
The Laryngoscope; 2006 May; 116(5); p. 770-5
Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia
Dwyer R; Ortqvist A; Aufwerber E; Henriques Normark B; Marrie TJ; Mufson MA; Torres A; Woodhead MA; Alenius M; Kalin M
European journal of clinical microbiology & infectious diseases; 2006 Aug; 25(8); p. 518-21
Airway-centered interstitial fibrosis related to exposure to fumes from cleaning products
Serrano M; Molina-Molina M; Ramirez J; Sanchez M; Xaubet A
Archivos de bronconeumologia; 2006 Oct; 42(10); p. 557-9
Alexithymia: a relevant psychological variable in near-fatal asthma
Serrano J; Plaza V; Sureda B; de Pablo J; Picado C; Bardagi S; Lamela J; Sanchis J
The European respiratory journal; 2006 Aug; 28(2); p. 296-302
Bruix J PI050150 FIS Perfil de expresión génica en lesiones preneoplásicas y en el carcinoma hepatocelular inicial, en la cirrosis por el virus de la hepatitis C. Aplicación en la detección precoz y en el diagnóstico
??? 2006-2008
Gines P
PI050246
FIS
Complicaciones de la cirrosis en pacientes en candidatos a trasplante hepático. Diseño de nuevas estrategias para la reducción de la mortali8dad en lista de espera de trasplante hepático
155.890
2005-2008
Gines P SAF2005-01917
Dirección General de Investigación
Efecto de la hiponatremia sobre la función neuropsicológica en los pacientes con cirrosis. Mecanismos patogénicos e intervenciones terapéuticas
71.400 ???
Gines P PI050246 FIS Complicaciones de la cirrosis en pacientes en candidatos a trasplante hepático. Diseño de nuevas estrategias para la reducción de la mortalidad en lista de espera de trasplante hepático.
155.890 2005-2008
Navasa M PI050230
FIS Evolución de la recidiva de la infección por el virus de la hepatitis C en trasplante hepático de donante vivo. Comparación con el trasplante convencional. Papel de las lipoproteinas en la efectividad del virus de la hepatitis C
46.410
2005-2008
Panes J Asociación Española de Gastroenterología
Efectos de las variantes del gen CARD15/NOD2 sobre los mecanismos de apoptosis
12.000
2004-2006
Panes J
P/N: 503569
European Commission for Research: The Sixth Framework
Network of Excellence of European Molecular Imaging Laboratories (EMIL)
84.530
2004-2007
Panes J C03/02 Instituto Carlos III Red Nacional de investigación en hepatología y gastroenterología
126.000 2003-2006
Panes J SAF2006-03074
Ministerio E y C. Programa I+D
Análisis de expresión génica en la enfermedad inflamatoria intestinal: relación con el fenotipo, progresión de la enfermedad y respuesta al tratamiento
175.000 2006
Panes J PSE-010000-2006-6
Ministerio de E y C Proyectos Científico-Tecnológicos Singulares
Desarrollo de un kit diganóstico para las enfermedades inflamatorias mediadas por mecanismos inmunes (IMID-Kit)
1.850.000 2006-2010
24
Alpha-1-Antitrypsin Deficiency: Optimal Therapeutic Regime Based On Population Pharmacokinetics
Soy D, de la Roza C, Lara B, Esquinas C, Torres A Thorax, 2006; 61(12): 1059-64
Association between habitual naps and sleep apnea.
Masa JF; Rubio M; Perez P; Mota M; de Cos JS; Montserrat JM
Sleep; 2006 Nov 1; 29(11); p. 1463-8
Barcelona Smell Test - 24 (BAST-24): validation and smell characteristics in the healthy Spanish population
Cardesin A; Alobid I; Benitez P; Sierra E; de Haro J; Bernal-Sprekelsen M; Picado C; Mullol J
Rhinology; 2006 Mar; 44(1); p. 83-9
Bench Model To Simulate Upper Airway Obstruction for Analyzing Automatic Continuous Positive Airway Pressure Devices
Jordi Rigau, Josep M Montserrat, Holger Wöhrle, Diana Plattner, et al
Chest. Chicago: Aug 2006.Vol. 130, Iss. 2; pg. 350, 12 pgs
Changes in markers of epithelial permeability and inflammation in chronic smokers switching to a nonburning tobacco device (Eclipse)
Stewart JC; Hyde RW; Boscia J; Chow MY; O'Mara RE; Perillo I; Pietropaoli A; Smith CJ; Torres A; Utell MJ; Frampton MW;
Nicotine & tobacco research; 2006 Dec; 8(6); p. 773-83
Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units
Martinez JA; Nicolas JM; Marco F; Horcajada JP; Garcia-Segarra G; Trilla A; Codina C; Torres A; Mensa J
Critical care medicine; 2006 Feb; 34(2); p. 329-36
Control of ventilation, breathlessness perception and alexithymia in near-fatal asthma
Plaza V; Giner J; Picado C; Sureda B; Serrano J; Casan P; Pablo JD; Sanchis J
The Journal of asthma; 2006 Oct; 43(8); p. 639-44
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease.
Chappell S; Daly L; Morgan K; Guetta Baranes T; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra P; Miniati M; Monti S; O'Connor CM; Kalsheker N
Human mutation; 2006 Jan; 27(1); p. 103-9
Depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index
Rabinovich RA; Ardite E; Mayer AM; Polo MF; Vilaro J; Argiles JM; Roca J
Respiration; international review of thoracic diseases; 2006; 73(6); p. 757-61
Differences in COPD care among doctors who control the disease: General practitioner vs. Pneumologist
García-Aymerich J, Escarrabill J, Marrades RM, Monsó E, Barreiro E, Antó JM, EFRAM investigators (Dr. A Torres como miembro del grupo)
Resp Med, 2006. 100: 332-9
Does Helicobacter pylori have a pathogenic role in bronchiectasis?
Angrill J; Sanchez N; Agusti C; Guilemany JM; Miquel R; Gomez J; Torres A
Respiratory medicine; 2006 Jul; 100(7); p. 1202-7
Early Noninvasive Ventilation Averts Extubation Failure in Patients at Risk: A Randomized Trial
Ferrer M; Valencia M; Nicolas JM; Bernadich O; Badia JR; Torres A
American journal of respiratory and critical care medicine; 2006 Jan 15; 173(2); p. 164
Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology; 2006 Jan; 36(1); p. 52-8
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome
Gomez FP; Barbera JA; Roca J; Burgos F; Gistau C; Rodriguez-Roisin R
Hepatology (Baltimore, Md); 2006 May; 43(5); p. 1084-91
Etiología y factores pronósticos de la neumonía adquirida en la comunidad en el adulto hospitalizado, Puerto Montt, Chile
Riquelme R, Riquelme M, Rioseco ML, Gómez V, Gil R, Torres A
Rev Med Chile, 2006; 134: 597-605
Experimental safety and efficacy evaluation of an extracorporeal pumpless artificial lung in providing respiratory support through the axillary vessels
Iglesias M; Jungebluth P; Sibila O; Aldabo I; Matute MP; Petit C; Torres A; Macchiarini P
The Journal of thoracic and cardiovascular surgery; 2007 Feb; 133(2); p. 339-45
25
Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis
Li X; Molina-Molina M; Abdul-Hafez A; Ramirez J; Serrano-Mollar A; Xaubet A; Uhal BD
merican journal of physiology Lung cellular and molecular physiology; 2006 Nov; 291(5); p. L887-95
Fungal pneumonia, chronic respiratory diseases and glucocorticoids
Agusti C; Rano A; Aldabo I; Torres A Medical mycology; 2006 Sep; 44 Suppl; p. 207-11
Hospitalized Community-Acquired Pneumonia Due to Streptococcus pneumoniae*: Has Resistance to Antibiotics Decreased?
Valles X; Marcos A; Pinart M; Piner R; Marco F; Mensa JM; Torres A
Chest; 2006 Sep; 130(3); p. 800
Identification of Vascular Progenitor Cells in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease
Peinado VI; Ramirez J; Roca J; Rodriguez-Roisin R; Barbera JA
American journal of respiratory cell and molecular biology; 2006 Mar; 34(3); p. 257-63
Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia
de Roux A; Cavalcanti M; Marcos MA; Garcia E; Ewig S; Mensa J; Torres A
Chest; 2006 May; 129(5); p. 1219
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Aspa J; Rajas O; Rodriguez de Castro F; Huertas MC; Borderias L; Cabello FJ; Tabara J; Hernandez-Flix S; Martinez-Sanchis A; Torres A
The European respiratory journal; 2006 May; 27(5); p. 1010-9
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
The European respiratory journal; 2006 Jun; 27(6); p. 1210-6
Influencia de las resistencias bacterianas sobre la eficiencia del tratamiento antibiótico de las agudizaciones de la bronquitis crónica en España
Sabés R, Segú JL, Puig-Junoy J, Torres A, Piñol C Pharmacoeconomics, 2006; 3 (3): 109-122
Integrated care prevents hospitalisations for exacerbations in COPD patients
Casas A; Troosters T; Garcia-Aymerich J; Roca J; Hernandez C; Alonso A; del Pozo F; de Toledo P; Anto JM; Rodriguez-Roisin R; Decramer M
The European respiratory journal; 2006 Jul; 28(1); p. 123-30
Integrating hospitals into community emergency preparedness planning
Braun BI; Wineman NV; Finn NL; Barbera JA; Schmaltz SP; Loeb JM
Annals of internal medicine; 2006 Jun 6; 144(11); p. 799
Is the incidence of near-fatal asthma decreasing in Spain?
Bellido Casado J; Plaza V; Bardagi S; Cosano J; Lopez Vina A; Martinez Moragon E; Rodriguez-Trigo G; Picado C; Sanchis J
Archivos de bronconeumologia; 2006 Oct; 42(10); p. 522-5
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis
Molina-Molina M; Serrano-Mollar A; Bulbena O; Fernandez-Zabalegui L; Closa D; Marin-Arguedas A; Torrego A; Mullol J; Picado C; Xaubet A
Thorax; 2006 Jul; 61(7); p. 604-10
Microbiologic features and outcome of pneumonia in transplanted patients
Cervera C; Agusti C; Angeles Marcos M; Pumarola T; Cofan F; Navasa M; Perez-Villa F; Torres A; Moreno A
Diagnostic microbiology and infectious disease; 2006 May; 55(1); p. 47-54
Mitochondrial dysfunction in copd patients with low body mass index
Rabinovich RA; Bastos R; Ardite E; Llinas L; Orozco-Levi M; Gea J; Vilaro J; Barbera JA; Rodriguez-Roisin R; Fernandez-Checa JC; Roca J
The European respiratory journal; 2006 Dec 20
Mixed community-acquired pneumonia in hospitalised patients
de Roux A; Ewig S; Garcia E; Marcos MA; Mensa J; Lode H; Torres A
The European respiratory journal; 2006 Apr; 27(4); p. 795-800
Mucin genes have different expression patterns in healthy and diseased upper airway mucosa
Martinez-Anton A; Debolos C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J
Clinical and experimental allergy; 2006 Apr; 36(4); p. 448-57
Nonspecific interstitial pneumonia: epidemiologic and clinical characteristics
Reyes LJ; Morell F; Xaubet A; Ramirez J; Majo J Medicina clinica; 2006 Jan 21; 126(2); p. 47-52
Performance of mechanical ventilators at the patient's home: a multicentre quality control study
Farre R; Navajas D; Prats E; Marti S; Guell R; Montserrat JM; Tebe C; Escarrabill J
Thorax; 2006 May; 61(5); p. 400-4
26
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required?
Macchiarini P; Kamiya H; Hagl C; Winterhalter M; Barbera JA; Karck M; Pomar J; Haverich A
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery; 2006 Aug; 30(2); p. 237-41; discussion 241-3
Quantifying plasma levels of transforming growth factor beta1 in idiopathic pulmonary fibrosis]
Molina-Molina M; Lario S; Luburich P; Ramirez J; Carrion MT; Xaubet A
Archivos de bronconeumologia; 2006 Aug; 42(8); p. 380-3
Recommendations for the use of equations to estimate glomerular filtration rate in adults. Spanish Society of Nephrology
Gracia S; Montanes R; Bover J; Cases A; Deulofeu R; Martin de Francisco AL; Orte LM
Nefrologia; 2006; 26(6); p. 658-65
Relation between rhinosinusitis and bronchiectasis
Guilemany JM; Mullol J; Picado C Archivos de bronconeumologia; 2006 Mar; 42(3); p. 135-40
Risk and prognostic factors of ventilator-associated pneumonia in trauma patients
Cavalcanti M; Ferrer M; Ferrer R; Morforte R; Garnacho A; Torres A
Critical care medicine; 2006 Apr; 34(4); p. 1067-72
Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment
Alobid I; Benitez P; Pujols L; Maldonado M; Bernal-Sprekelsen M; Morello A; Picado C; Mullol J
Rhinology; 2006 Mar; 44(1); p. 8-13
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation
Martinez-Palli G; Gomez FP; Barbera JA; Navasa M; Roca J; Rodriguez-Roisin R; Burgos F; Gistau C
World journal of gastroenterology : WJG; 2006 Sep 28; 12(36); p. 5878-83
Systemic effects of cigarette smoke exposure in the guinea pig
Ardite E; Peinado VI; Rabinovich RA; Fernandez-Checa JC; Roca J; Barbera JA
Respiratory medicine; 2006 Jul; 100(7); p. 1186-94
Telemedicine experience for chronic care in COPD.
de Toledo P; Jimenez S; del Pozo F; Roca J; Alonso A; Hernandez C
IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society; 2006 Jul; 10(3); p. 567-73
The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis
Alobid I; Benitez P; Valero A; Berenguer J; Bernal-Sprekelsen M; Picado C; Mullol J
Otolaryngology--head and neck surgery; 2006 Apr; 134(4); p. 609-12
The impact of bronchiectasis associated to sinonasal disease on quality of life
Guilemany JM; Alobid I; Angrill J; Ballesteros F; Bernal-Sprekelsen M; Picado C; Mullol J
Respiratory medicine; 2006 Nov; 100(11); p. 1997-2003
The role of viruses in the aetiology of community-acquired pneumonia in adults
Angeles Marcos M; Camps M; Pumarola T; Antonio Martinez J; Martinez E; Mensa J; Garcia E; Penarroja G; Dambrava P; Casas I; Jimenez de Anta MT; Torres A
Antiviral therapy; 2006; 11(3); p. 351-9 SFX
Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis
Roca-Ferrer J; Pujols L; Gartner S; Moreno A; Pumarola F; Mullol J; Cobos N; Picado C
Thorax; 2006 Jul; 61(7); p. 592-6
Revisió A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis
Blasi F; Ewig S; Torres A; Huchon G Pulmonary pharmacology & therapeutics; 2006; 19(5); p. 361-9
ABS75: Asthma treatment in Spain - Study in primary care and Pneumology Services
Cimas JE; Coira G; Lopez-Vina A; Sanchez CD; Vegazo O; Picado C
Primary care respiratory journal : journal of the General Practice Airways Group; 2006 May 20;
Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/ pharmacodynamic principles
Soy D, Torres A Curr Opin Crit Care, 2006; 12 (5): 477-82
27
Antibiotic dosage regimens in respiratory tract infections in the pharmacokinetic /pharmacodynamic era
Soy D, Badia JR, Torres A Current Respiratory Medicine Reviews. 2006, 2: 89-7
Antibióticos en la exacerbación aguda de la EPOC ¿Qué lugar ocupa Cefditoren?
Martínez P, Torres A Med Clin Monogr, 2006, 7 (6): 327-338
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane database of systematic reviews (Online); 2006 Apr 19; (2); p. CD004403
Associated inflammatory response in pneumonia: role of adjunctive therapy with glucocorticoids
Rano A; Agusti C; Sibila O; Torres A Current opinion in infectious diseases; 2006 Apr; 19(2); p. 179-84
Conducta y tratamiento en la neumonía adquirida en la comunidad
Martínez-Olondris P, Torres A Jano, 2006; 1595: 43-6
COPD exacerbations.5: management
Rodriguez-Roisin R Thorax; 2006 Jun; 61(6); p. 535-44
Formación troncal de las especialidades médicas; Un reto del presente para una mejora del sistema sanitario
Teres J, Capdevila JA, Nonell F, Cardellach F, Bundó M, Torres M (Torres A, como miembro y coautor de la Comisión de Medicina y Especialidades Relacionadas dels Consell Català d’Especialitats en Ciències de la Salut)
Med Clin (Barc), 2006; 127 (4): 139-44
Intermediate Respiratory Care Units Ferrer M, Martínez P, Torres A Clin Pulm Med, 2006; 13 (5): 1-7 Mechanisms of aspirin sensitivity Picado C Current allergy and asthma reports;
2006 May; 6(3); p. 198-202 Nosocomial pneumonia Ostendorf U; Ewig S; Torres A Current opinion in infectious diseases;
2006 Aug; 19(4); p. 327-38 Respiratory infections after lung cancer resection
Belda J, Cavalcanti M, Iglesias M, Gimferrer, JM, Torres A
Clin Pulmonary Med, 2006; 13 (1): 8-16
Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
Picado C Expert opinion on pharmacotherapy; 2006 Oct; 7(14); p. 1989-2001
Surviving collapsed structure entrapment after earthquakes: a "time-to-rescue" analysis
Macintyre AG; Barbera JA; Smith ER Prehospital and disaster medicine; 2006 Jan-Feb; 21(1); p. 4-17; discussion 18-9
Tratamiento antimicrobiano de la enfermedad pulmonar obstructiva crónica en el anciano
Torres A, Quintano JA, Martínez M, Rodríguez C, Prieto J, Zalacaín R
Rev Esp Geriatr Gerontol, 2006; 41(6): 362-77
Tratamiento antimicrobiano de la enfermedad pulmonar obstructiva crónica en el anciano
Torres A, Quintano JA, Martínez M, Rodríguez C, Prieto J, Zalacaín R
Arch Bronconeumol, 2006; 42 (3): 1-15
Tratamiento antimicrobiano de la EPOC en el anciano
Torres A, Quintano JA, Martínez M, Rodríguez C, Prieto J, Zalacaín R
Rev Esp Quimioterap, 2006; 19 (2): 167-83
Treatment failure in patients with ventilator-associated pneumonia
Dominguez AA; Arango MV; Torres A Seminars in respiratory and critical care medicine; 2006 Feb; 27(1); p. 104-14
Two decades of imipenem therapy Rodloff AC, Goldstein EJC, Torres A J Antimicrobial Chemotherapy (JAC), 2006; 58(5): 916-29
Cas Clínic Pulmonary varix inside a bulla Sellares J; Santos S; Ballester E; Barbera JA Archivos de bronconeumologia; 2006
Jan; 42(1); p. 39-41 Tuberculosis, ancylostomiasis and eosinophilic pleural effusion
Rodriguez E; Delgado Y; Buges J; Bastida T; Torres M
Anales de medicina interna (Madrid, Spain : 1984); 2006 Jan; 23(1); p. 46-7
Editorial
28
Assessment of pneumonia severity: a European perspective
Ewig S; Torres A; Woodhead M The European respiratory journa; 2006 Jan; 27(1); p. 6-8
Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD
Celli B; Cross S; Grossman R; Kardos P; Myrseth SE; Rodriguez-Roisin R; Vestbo J
Primary care respiratory journal; 2006 Jun; 15(3); p. 139-42
Mortality in COPD patients with community-acquired pneumonia: who is the third partner?
Torres A; Menendez R The European respiratory journal; 2006 Aug; 28(2); p. 262-3
Respiratory infections after lung cancer resection
Torres A Expert review of anti-infective therapy; 2006 Oct; 4(5); p. 717-20
The new American Thoracic Society/Infectious Disease Society of North America guidelines for the management of hospital-acquired, ventilator-associated and healthcare-associated pneumonia: a current view and new complementary information
Torres A Current opinion in critical care; 2006 Oct; 12(5); p. 444-5
Llibre ¿Qué pacientes con neumonía adquirida en la comunidad debemos derivar al hospital para valorar ingreso hospitalario? Preguntas al experto sobre enfermedades infecciosas
Torres A, Dambrava P (1ª edición), 2006; 1: 99-106 ISBN: 84-690-0302-X
Casos Clínicos de residentes de Neumología y Cirugía Torácica 2005-2006
Álvarez-Sala JL, Torres A, Viejo JL ISBN: 84-7989-400-8. S.A. de Ediciones, Madrid (España), 2006
Clinical Criticare Care Medicine Albert R, Ranieri M, Takala J, Slutsky A, Torres A ISBN-13: 978-0-323-02844-8 ISBN-10: 0-323-02844-6 Editorial Elsevier 2006, Philadelphia, USA
Interacción cardiopulmonar y transporte gaseoso
Barberà J.A. Madrid: Sanitaria 2000, 2006.
Manual de auscultación pulmonar. Imágenes y sonidos en neumología
Ferrer M, Torres A ISBN:84-7877-428-9.Edikamed, Barcelona, 2006
Normativa sobre valoración del riesgo quirúrgico en el carcinoma broncogénico
Varela G., Barberà J.A., Cordovilla R., Duque J.L., López-Encuentra A., Puente L.
Barcelona: Doyma, 2006.
Respiratorio y atención primaria Torres A, Naberán K Depósito legal : B-950-06 JC Ediciones Médicas, S.L.. Barcelona (España), Vol 1:1, 2006
Técnicas y procedimientos en hipertensión pulmonar. Manual SEPAR de Procedimientos -10
Barberà J.A., Valera J.L., eds. Barcelona: Permanyer, 2006.
Woodhead M Respiratory Infections Torres A, Ewig S, Mandell L ISBN-10: 0-340-81694-5 ISBN-13: 978-0-340-81694-3 Editorial: Hodder Headline Group, 2006 Arnold, London, 2006
Capítol Llibre ¿Qué pacientes con neumonía adquirida en la comunidad debemos derivar al hospital para valorar ingreso hospitalario?
Torres A, Dambrava P
Preguntas al experto sobre enfermedades infecciosas (1ª edición), 2006; 1: 99-106 ISBN: 84-690-0302-X. Depósito Legal: M-35216-2006
29
Circulación pulmonar en la insuficiencia respiratoria
Pizarro S., Peinado V.I., Barberà J.A. En: De Lucas P., Güell R., Rodríguez J.M., Antón A., eds. Tratado de insuficiencia respiratoria. Madrid, SEPAR, 2006; 49-58.
Diagnostic approach in ventilator-associated pneumonia
Alcon A, Fábregas N, Torres A
En: Respiratory Infections. Torres A, Ewig S, Mandell L, Woodhead M ISBN-10: 0-340-81694-5. ISBN-13: 978-0-340-81694-3 Editorial: Hodder Headline Group, 2006. Capítulo 41.
Distrés respiratorio del adulto Sellarés J, Ferrer M, Torres A
En: Tratado de insuficiencia respiratoria. SEPAR. ISBN: 84-8473-498-6
Emergency treatment of community-acquired pneumonia.
Valencia M, Sellares J, Torres A
En: Respiratory Emergencies. Nava S, Welte T. Hardback ISBN:1-904097-38-3. Paperback ISBN: 1-904097-42-1 ISSN: 1025-448x European Respiratory Monograph. 2006; 36(11): 183-199
Enfermedades intersticiales difusas. Fiblosis pulmonary idiopática
Xaubet A En: Medicina Respiratoria 2ª edición. Ed. SEPAR. Editores: Martín P, Ramos G, Sanchis J Sección VIII Capitulo 54: 953-969 ISBN: 84-7885-401-0
Epidemiology of nosocomial respiratory infection
Bauer T, Torres A En: Respiratory Infections. Torres A, Ewig S, Mandell L, Woodhead M ISBN-10: 0-340-81694-5. ISBN-13: 978-0-340-81694-3 Editorial: Hodder Headline Group, 2006. Capítulo 38
Estudio hemodinámico pulmonar y prueba vasodilatadora aguda
Valera J.L., Melgosa M.T., Barberà J.A. En: Barberà J.A., Valera J.L., eds.Técnicas y procedimientos en hipertensión pulmonar. Manual SEPAR de Procedimientos – 10. Barcelona: Permanyer, 2006; 17-35.
Hipertensión pulmonar Barberà JA En: Alvarez-Sala J.L., Celli B., Torres A., eds. Enfermedades pulmonares vasculares. Respiratory disease self-assessment program. Medical Trends, 2006; 3-8.
Interacciones entre intercambio gaseoso pulmonar y periférico
Roca J En: Barberà J.A., ed. Interacción cardiopulmonar y transporte gaseoso. Madrid: Sanitaria 2000, 2006. 63-81
La proyección internacional de la SEPAR
Rodríguez-Roisin R
En: Historia de la neumología y la cirugía torácica españolas
La SEPAR del siglo XXI
Torres A
En: Historia de la neumología y cirugía torácica Española Editor: JL Álvarez Sala ISBN: 84-689-8759-X. Depósito Legal: M-23374-2006
Neumonía adquirida en la comunidad. Epidemiología, Etiología. Clínica.
Torres A
En: Medicina respiratoria, segunda edición. P. Martín, G. Ramos, J. Sanchis. ISBN: 84-7885-401-0. Depósito Legal: M-12702-2005 SEPAR. Aula medica, Barcelona, 2006; Capítulo 46.1: 817-830.
30
Neumonía intrahospitalaría
Torres A
En: Patología infecciosa respiratoria Depósito Legal: B-48.989.2004. Ed. Doyma Update, 2006
Non-invasive Ventilation for Respiratory Failure after Extubation.
Sellares J, Ferrer M, Torres A
En: 2006 Yearbook of Intensive Care and Emergency Medicine. Vincent JL. ISBN: 3-540-30155-0. Editorial Springer Verlag, Berlín (Alemania), 2006. Páginas: 494-501
Nosocomial Pneumonia Torres A, Valencia M, Sellarés J En: Encyclopedia of Respiratory Medicine, 2006
Nuevos retos en el tratamiento antibiótico de la Exacerbación de la EPOC.
Torres A En: 32 Simposio de Neumología. Asma y EPOC. Burgos, 20-21 oct de 2006: 55-68 Depósito Legal: BU-428-2006. Editor: J.L. Viejo Bañuelos
Pruebas de provocación nasal Bartra J, Valero AL, Picado C
En: Estudio de la función respiratoria. Ed. Sanitaria 2000. Pino JM, García F. ISBN: 84-611-2158-9. Cap. 5: 131-154.
Regulación del tono vascular pulmonar. En: Barberà J.A., ed. Interacción cardiopulmonar y transporte gaseoso
Peinado V.I., Barberà J.A. Madrid, Sanitaria 2000, 2006; 83-116.
Tratamiento de las agudizaciones de la EPOC
Soler L, Martinez P, Pizarro S, Torres A En: Infección 2004 Editores: Picazo JJ, Bouza E
Tratamiento en las infecciones respiratorias comunitarias.
Martínez-Olondris P, Pizarro S, Soler N, Torres A
En: Antimicrobianos en medicina. Prous Science. ISBN: 978-81-8124-240-9
Un nuevo paradigma: Utilidad potencial de los antibióticos en las agudizaciones del asma. El estudio Telicast.
Torres A
En: 32 Simposio de Neumología. Asma y EPOC. Burgos, 20-21 oct de 2006: 101-106 Depósito Legal: BU-428-2006. Editor: J.L. Viejo Bañuelos
Unidades de cuidados intermedios respiratorios
Ferrer M, Martinez-Olondris P, Torres A En: Tratado de insuficiencia respiratoria Editores: Pilar de Lucas, Rosa Güell, José Miguel Rodríguez, Antonio Antón ISBN: 84-8473-498-6
Ventilator-Associated Pneumonia Torres A, Alcón A, Fabregas N
En: Clinical Critical Care Medicine. Albert RK, Slutsky A, Ranieri M, Tácala J, Torres A ISBN: 0-323-02844-6. Editorial Elsevier, 2006. Capítulo 19. 175-186
Carta The SERPINE2 gene and chronic obstructive pulmonary disease
Chappell S; Daly L; Morgan K; Baranes TG; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra PS; Miniati M; Monti S; O'Connor CM; Kalsheker N
American journal of human genetics; 2006 Jul; 79(1); 184-6; author reply 186-7
31
Malalties de l'Aparell Respiratori - Projectes de recerca finançats 2006 Inv. Principal Ref. Ajut Entitat Títol Import € Durada Barberà JA PI041424 FIS Bases moleculares y celulares del daño vascular,
pulmonar y sistémico, asociado a situaciones de hipoxia continua o intermitente: implicaciones en la enfermedad pulmonar obstructiva cr´`onica y el síndrome de apneas durante el sueño.
140.875 2005-2007
Barberà JA PI050244 FIS Contribución de las celulas progenitoras vasculares en los mecanismos de reparación y remodelado de la circulación pulmonar en la enfermedad pulmonar obstructiva crónica
164.220 2005-2008
Barberà JA SLMM-CT-2005-018725
Unió Europea (6th FWP)
Pulmonary hipertensión: Functional genomics and therapy of lung vascular remodelling (PULMOTENSION)
315.677 2005-2009
Barberà JA PI031685 FIS Estudio epidemiológico de las repercusiones clínicas, funcionales y biológicas de la exposición al vertido de fuel del buque Prestige sobre la salud respiratoria en marineros de la costa de Galicia
485.300 2003-2006
Barberà JA 040310 Fundació La Marató de TV3
Estudi de la contribució de les cèl•lules progenitores vasculars en els mecanismes de lesió i reparació vascular a la circulació pulmonar en la malaltia pulmonar obstructiva crònica (MPOC)
140.000 2005-2008
Picado C PI050108 FIS Estudio de la relación entre la intolerancia a los antiinflamatorios no esteroideos y la producción de PGE2 con la gravedad del asma
119.000 2005-2008
Roca J PI050282 FIS Nuevos modelos de prestación de servicios sanitarios utilizando telemedicina
20.349 2005-2008
Roca J C510866 Unió Europea. Healt Telematics Program
SPEX (Spreading Excellence in healthcare) 124.636 2004-2006
Roca J C510743 Unió Europea. Healt Telematics Program
Ward in Hard 95.861 2004-2006
Roca J 508015 Unió Europea. Healt Telematics Program
Doc@Hand(Knowledge sharing and decision support for healthcare professionals)
228.400 2004-2006
Roca J 42010 La Marató de TV3 Atenció Integrada i biopatologia de la MPOC avançada 149.088 2005-2007
Roca J 517352 Unión Europea -eTEN HealthService24 - Continuous Mobile services for Healthcare
136.400 2005-2006
Roca J 517535 Unión Europea -eTEN LINKCARE -Linking Health Professionals in Emerging Care Environments
250.689 2005-2006
Roca J 017333
Unió Europea (6th FWP) Careman (Healthcare by Biosensor Measurements and Networking)
203.670 2005-2008
Roca J PI061510 FIS Entrenamiento muscular y actividad física en la EPOC
83.490 2006-2009
Roca J C029402
Unión Europea - eTEN Remote Health Monitoring with Wearable Non-Invasive Mobile System (HealthWear)
142.812 2006-2008
Roca J 037939 Unión Europea – FP6 Integrative Genomics and Chronic Disease Phenotypes: modelling and simulation tools for clinicians (BioBridge)
450.000 2006-2009
Torres A PI050136 FIS Modelo animal de neumonía asociada a la ventilación mecánica (NAVM). Estudio de la respuesta inflamatoria asociada y su modulación por glucocorticoides
121.618 2006-2009
Torres A CB06/06/0028 Instituto de Salud Carlos III
CIBER: enfermedades respiratorias
120.000 2006-2007
Torres A ?? FIS Contratos de apoyo a la Investigación del Sistema Nacional de Salud
24.000 2006-2009
Torres A ?? SEPAR Modelo animal de neumonía asociada a la ventilación mecánica (NAVM). Estudio de la respuesta inflamatoria asociada y su modulación por glucocorticoides
18.000 2006
32
Malalties del Sistema Endocrí i de la nutrició
Malalties Sistema Endocrí i de la nutrició - Publicacions 2006 Títol Autors Cita Original A FoxO-Smad synexpression group in human keratinocytes
Gomis RR; Alarcon C; He W; Wang Q; Seoane J; Lash A; Massague J
Proceedings of the National Academy of Sciences of the United States of America; 2006 Aug 22; 103(34); p. 12747-52
Análisis coste-utilidad de las bombas de insulina frente a múltiples dosis diarias de insulina en pacientes con Diabetes tipo I en España
Conget I, Rodríguez JM, Levy I, Castell C, Roze S, Serrano D
Rev. Esp. Salud Pública 2006;80:679-695
Assessment and control of metabolic and cardiovascular risk in patients with schizophrenia
Rodriguez-Artalejo F; Baca E; Esmatjes E; Merino-Torres JF; Monereo S; Moreno B; Mories T; Roca M; Salvador J; Sanmarti A
Medicina clinica; 2006 Oct 14; 127(14); p. 542-8
C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
Gomis RR; Alarcon C; Nadal C; Van Poznak C; Massague J
Cancer cell; 2006 Sep; 10(3); p. 203-14
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
Hoogma RP; Hammond PJ; Gomis R; Kerr D; Bruttomesso D; Bouter KP; Wiefels KJ; de la Calle H; Schweitzer DH; Pfohl M; Torlone E; Krinelke LG; Bolli GB
Diabetic medicine : a journal of the British Diabetic Association; 2006 Feb; 23(2); p. 141-7
Correlated mutations: advances and limitations. A study on fusion proteins an on the Cohesin-Dockerin families.
Halperin I, Wolfson H, Nussionov R. Proteins. 2006 Jun 1;63(4):832-45.
Effect of ramipril on the incidence of diabetes
The DREAM trial investigators (I Conget, Steering Committee)
N. Engl. J. Med. 2006;114:1551-62
Effect of rosiglitazone on the requency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
The DREAM trial investigators (I Conget, Steering Committee)
Lancet 2006;368:1096-105
Estrategias para un control eficaz de la hipertensión arterial en España. Documento de consenso.
Coca A, Aranda P, Bertnomeu V, Bonet A, Esmatjes E, Guillén F, Hernández J, Llisterri JL, Marín R, Megía C, Rodríguez L.
Semergen 2006;32(7):330-333.
GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.
Morinigo R; Lacy AM; Casamitjana R; Delgado S; Gomis R; Vidal J
Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand; 2006 Dec; 16(12); p. 1594-601
Hepatitis C virus and splenic marginal zone lymphoma with villous lymphocytes: Hawai from conventional therapy.
Gurvits GE, Matan R, Halperin I. Scand. J. Gastroenterol. 2007 Jul 20;1-2
Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes.
Musri MM; Corominola H; Casamitjana R; Gomis R; Parrizas M
The Journal of biological chemistry; 2006 Jun 23; 281(25); p. 17180-8
33
Improving metabolic control in sub-optimally controlled subjects wity Type 1 diabetes: comparison of two tretament algorithms using insulin glargine.
Gomis R, Storms F, Conget I, Sinnassamy P, Davies M.
Diab. Res. Clin. Pract . 2006
Inhibition of GSK3 dependent tau phosphorylation by metals
Gomez-Ramos A; Dominguez J; Zafra D; Corominola H; Gomis R; Guinovart JJ; Avila J
Current Alzheimer research; 2006 Apr; 3(2); p. 123-7
Intra-abdominal fat adiponectin receptors expresión and cardiovascular metabolic risk factors in obesity and diabetes.
Morinigo R, Musri M, Vidal J, Casamitjana R, Delgado S, Laci AM, Ayuso C, Gomis R, Corominola H.
Obes. Surg. 16(6):745-751
Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes
Morinigo R; Musri M; Vidal J; Casamitjana R; Delgado S; Lacy AM; Ayuso C; Gomis R; Corominola H
Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand; 2006 Jun; 16(6); p. 745-51
Nefropatía diabética: de la hiperfiltración glomerular al trasplante renal.
Esmatjes E. Avances en diabetología 2006;22(2):2-4.
Prognostic significance of the white coat hypertension in patients with type 1 diabetes mellitus
Flores L; Gimenez M; Esmatjes E Diabetes research and clinical practice; 2006 Oct; 74(1); p. 21-5
Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation.
Gomez-Ramos A; Dominguez J; Zafra D; Corominola H; Gomis R; Guinovart JJ; Avila J
Journal of neuroscience research; 2006 Feb 1; 83(2); p. 264-73
Strategies for effective control of arterial hipertensión in Spain. Consensus document
Coca A, Aranda P, Bertomeu V, Bonet A, Esmatjes E, Guillén F, Hernández-Moreno J, Llisterri JL, Marín-Iranzo R, Megia C, Rodríguez-Manas L, Suárez C.
Rev. Clin. Esp. 2006 Nov; 2006(10): 510-4
Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control
Jansa M; Vidal M; Viaplana J; Levy I; Conget I; Gomis R; Esmatjes E
Diabetes research and clinical practice; 2006 Oct; 74(1); p. 26-32
Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control.
Jansa M; Vidal M; Viaplana J; Levy I; Conget I; Gomis R; Esmatjes E
2006 Oct; 74(1); p. 26-32
The logic of TGFbeta signaling Massague J; Gomis R FEBS letters; 2006 May 22; 580(12); p. 2811-20
Therapeutic educations seminars for patines.
Vidal M, Jansà M, Levy I, Jiménez M, Herrera F, Lorente I, Marín MC, Oriell J, Sanhonorato J, Sanz O, Conget I.
Eur. Diabetes Nursing 2006:3:132-136.
Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study
Coca A; Dalfo A; Esmatjes E; Llisterri JL; Ordonez J; Gomis R; Gonzalez-Juanatey JR; Martin-Zurro A
Medicina clinica; 2006 Feb 18; 126(6); p. 201-5
Young adult onset diabetes mellitus. Clinical differences between MODY-3 and type 2 diabetes mellitus
Conget I; Gimenez M; Nicolau J; Costa A; Oriola J; Casamitjana R;
Medicina clinica; 2006 May 6; 126(17); p. 651-2
Revisió Algoritmo terapéutico de la Diabetes mellitus tipo 1.
Giménez M, Conget I. Endocrinol. Nutr. 2006;53 (Supl. 2):4-6.
Endocrine evaluation of patients after brain injury: what else is needed to define specific clinical recommendations?
Sesmilo G, Halperin I, Puig-Domingo M. Hormones (Athens). 2007 Apr-Jun;6(2):132-7.
34
La prevención de la diabetes mellitus de tipo 2 ¿realidad o sueño? A propósito de los resultados del estudio DREAM.
Conget I, Giménez M. Av. Diabetol. 2006;22:112-114.
Mild cognitive impairment (MCI): characteristics, risk factors and prevention
Halperin I, Korczyin AD Harefuah. 2006 Mar;145(3):229-34,243.
Síndrome metabólico. Definición y epidemiología.
Giménez M, Nicolau J, Conget I. Rev. Clin.Esp. 2006;206 (Supl. 1) 3-6.
Carta Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route
Conget I; Piquer S; Julia M; Gomis R; Esmatjes E; Garcia-Pagan JC; Bosch J; Gilabert R; Ricart MJ; Fernandez-Cruz L; Manyalich M
Transplantation; 2006 Apr 27; 81(8); p. 1220-1
Llibre La fi de la diabetes? Cèl.lules mare, l’esperança de la biomedicina.
Gomis R. Edicions Bromera-Publicacions Univ. De Valencia-Càtedra de divulgació de la Ciencia. Alzira, 2006.
Prediabetes y diabetes tipo 1 de reciente diagnóstico.
Conget I. (Coordinador) Biblioteca de la Sociedad Española de Diabetes. Sociedad Española de Diabetes-Ediciones Mayo. Barcelona, 2006.
Capítol Llibre Prólogo. Pie diabético. Conget I. En: Guía práctica para la prevención,
evaluación y tratamiento.J Viadé. Ed. Panamericana. Madrid, 2006
Malalties del Sistema Endocrí i de la Nutrició - Projectes Finançats 2006 Investigador Principal Referència Ajut Entitat Nom Projecte Import Durada Conget I Ajut Contracte associat a
projecte de recerca Hospital Clínic i Universitari
Sistemas de infusión subcutánea continua de insulina y de monitorización continua de la glucosa en la Diabetes de Tipo 1. Efecto sobre el perfil de riesgo cardiovascular de los pacientes con control lábil por hipoglucemias recurrentes y severas.
24.000 2006-2009
Conget I PI060250 FIS Sistemas de infusión subcutánea continua de insulina y de monitorización continua de la glucosa en la Dibetes de Tipo 1. Efecto sobre el perfil de riesgo cardiovascular de los pacientes con control lábil por hipoglucemias recurrentes y severas.
57.475 2006-2009
Esmatjes E PI070124 FIS Efectos del by-pass gástrico sobre la presión arterial y la disfunción endotelial en personas con obesidad grave
44.770 2006
Gomis R CE503245-0 CEE Coordination action on the aetiology, pathology and prediction of type 1 diabetes in Europa (TONECA)
32.957,60 2004 -2008
Gomis R RD06/0015/00 FIS REDIMET-Red de diabetes y enfermedades metabólicas asociadas 450.000 2007-2010 Gomis R 2005SGR00019 ? Diabetes i alteracions metabòliques. Investigació cel.lular i molecular
en diabetis i obesitat 50.600 2005-2008
Gomis R Genoma_ES 06/409 ? Banco Nacional de ADN-Nodo de Metabólicas 212.677 2006-2009 Gomis R PI042553 FIS Efecto del tungstato sobre el síndrome metabólico: dianas moleculares 106.950 2005-2007 Gomis R PI051264 FIS Defectos moleculares en la diabetes mellitus: terapia genética y
celular. 41.769 2006
Gomis R 051241 FIS Biocomunicación celular y redes moleculares en enfermedades metabólicas
136.255 2006
Gomis R SAF2006-07382 ? Dianas moleculares inducidas por tungstato en la obesidad 677.600 2006-2011 Gomis R LSHM-CT-2004-503245 ? Coordinated action on the aetiology, pathology and prediction of type 1
diabetes in Europe (TONECA) 33.500 2004-2008
35
Malalties del Sistema Excretor Renal i Genital Masculí
Malalties del Sistema Excretor Renal i Genital Masculí - Publicacions 2006 Títol Autors Cita Original Automedida de la presión arterial domiciliaria. Influencia del sistema de cáculo de la media en el diagnóstico de la Hipertensión de bata blanca
J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX Naberan, A. Botey
Aten Primaria 2006;38:212-8
Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis
Gomez-Puerta JA; Salgado E; Cervera R; Aguilo S; Ramos-Casals M; Soler M; Torras A; Font J
Clinical and experimental rheumatology; 2006 Jan-Feb; 24(1); p. 110
Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria
Saurina A; Campistol JM; Piera C; Diekmann F; Campos B; Campos N; de las Cuevas X; Oppenheimer F
Nephrology, dialysis, transplantation; 21(2); p. 488-93
Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?
Campistol JM Nature clinical practice Nephrology; 2006 Apr; 2(4); p. 192-3
Gastrointestinal stromal tumors Darnell A; Dalmau E; Pericay C; Musulen E; Martin J; Puig J; Malet A; Saigi E; Rey M
Abdominal imaging; 2006 Jul-Aug; 31(4); p. 387
Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version
Marin R; Goicoechea MA; Gorostidi M; Cases A; Diez J; Escolar G; Fernandez-Vega F; Palomar R; Rodrigo E; Martinez I; Segura J
Nefrologia; 2006; 26(1); p. 31-44
Home blood presure self-monitoing: diagnostic performance in white-coat hypertension
J. Bayó, FX Cos, C. Roca, A. Dalfó, MM Martín-Baranera, A. Botey
Blood Presure Monitoring 2006; 11:47-52
Implication of chromosome 18 in hypertension by sibling pair and association analyses: putative involvement of the RKHD2 gene
Guzman B; Cormand B; Ribases M; Gonzalez-Nunez D; Botey A; Poch E
Hypertension; 2006 Nov; 48(5); p. 883-91
Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction
Ruiz JC; Campistol JM; Sanchez-Fructuoso A; Rivera C; Oliver J; Ramos D; Campos B; Arias M; Diekmann F
Nephrology, dialysis, transplantation 2006 Nov; 21(11); p. 3252-7
Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years
Marcen R; Morales JM; del Castillo D; Campistol JM; Seron D; Valdes F; Anaya F; Andres A; Arias M; Bustamante J; Capdevila L; Escuin F; Gil-Vernet S; Gonzalez-Molina M; Lampreave I; Oppenheimer F; Pallardo L
Transplantation proceedings; 2006 Dec; 38(10); p. 3530-2
Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients
Andres V; Castro C; Campistol JM Nephrology, dialysis, transplantation: 2006 Jul; 21 Suppl 3; p. iii14-7
Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study
Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
Nephrology, dialysis, transplantation; 2006 Feb; 21(2); p. 459-65
36
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
Campistol JM; Eris J; Oberbauer R; Friend P; Hutchison B; Morales JM; Claesson K; Stallone G; Russ G; Rostaing L; Kreis H; Burke JT; Brault Y; Scarola JA; Neylan JF
Journal of the American Society of Nephrology : JASN; 2006 Feb; 17(2); p. 581-9
Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?
Puig J; Darnell A; Bermudez P; Malet A; Serrate G; Bare M; Prats J
European radiology; 2006 Apr; 16(4); p. 939-43
Treatment of hepatitis C in hemodialysis patients and renal transplant recipients
Barrera J; Campistol JM Gastroenterologia y hepatologia; 2006 Oct; 29 Suppl 2; p. 158-62
Usefulness of 111In-oxine labelled platelets in the management of febrile syndrome in dialysis patients with non-functional renal allografts
Ortin-Perez J; Fuster D; Lomena F; Torregrosa JV; Piera C; Rodriguez-Puig D; Duch J; Rubi S; Setoain X; Campistol JM; Pons F
Revista espanola de medicina nuclear; 2006 Sep; 25(5); p. 289-93
Revisió Chronic transplant nephropathy Hernandez D; Sanchez Fructuoso A; Seron D; Arias
M; Campistol JM; Morales JM; Alonso A; Andres A; del Castillo D; Gentil MA; Gonzalez-Molina M; Gonzalez Posada JM; Moreso F; Oppenheimer F; Pallardo LM; Sola R
Nefrologia; 2006; 26 Suppl 1; p. 1-38
Cas Clínic Renal cortical necrosis after kidney transplantation associated with the prothrombin 20210A mutation
Quintana LF; Cofan F; Reverte JC; Oppenheimer F; Campistol JM
Nephrology, dialysis, transplantation; 2006 May; 21(5); p. 1455-6
Editorial A year of advancement and reflection in nephrology science
Cases A Drug news & perspectives; 2006 Mar; 19(2); p. 121-7
Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks
Diekmann F; Campistol JM Nephrology, dialysis, transplantation; 2006 Mar; 21(3); p. 562-8
Malalties del Sistema Nerviós
Malalties del Sistema Nerviós - Publicacions 2006 Títol Autors Cita Original 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism
Gaig C; Marti MJ; Tolosa E; Valldeoriola F; Paredes P; Lomena FJ; Nakamae F
Movement disorders; 2006 Nov; 21(11); p. 1994-8
Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice
Justicia C; Martin A; Rojas S; Gironella M; Cervera A; Panes J; Chamorro A; Planas AM
Journal of cerebral blood flow and metabolism; 2006 Mar; 26(3); p. 421-32
Blood lead levels in children and environmental lead contamination in Miami inner city, Florida
Gasana J; Hlaing WM; Siegel KA; Chamorro A; Niyonsenga T
International journal of environmental research and public health; 2006 Sep; 3(3); p. 228-34
Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules
Drumea-Mirancea M; Wessels JT; Muller CA; Essl M; Eble JA; Tolosa E; Koch M; Reinhardt DP; Sixt M; Sorokin L; Stierhof YD; Schwarz H; Klein G
Journal of cell science; 2006 Apr 1; 119(Pt 7); p. 1396-405
CLEAR-test: Combining inference for differential expression and variability in microarray data analysis
Valls J; Grau M; Sole X; Hernandez P; Montaner D; Dopazo J; Peinado MA; Capella G; Moreno V; Pujana MA
Journal of biomedical informatics; 2007 May 17
37
Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials?
Vargas M; Horcajada JP; Obach V; Revilla M; Cervera A; Torres F; Planas AM; Mensa J; Chamorro A
Stroke; a journal of cerebral circulation; 2006 Feb; 37(2); p. 461-5
Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study
Blanco Y; Moral EA; Costa M; Gomez-Choco M; Torres-Peraza JF; Alonso-Magdalena L; Alberch J; Jaraquemada D; Arbizu T; Graus F; Saiz A
Neuroscience letters; 2006 Oct 9; 406(3); p. 270-5
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force
Soffietti R; Cornu P; Delattre JY; Grant R; Graus F; Grisold W; Heimans J; Hildebrand J; Hoskin P; Kalljo M; Krauseneck P; Marosi C; Siegal T; Vecht C
European journal of neurology; 2006 Jul; 13(7); p. 674-81
End-of-dose wearing off in Parkinson disease: a 9-question survey assessment
Stacy M; Hauser R; Oertel W; Schapira A; Sethi K; Stocchi F; Tolosa E
Clinical neuropharmacology; 2006 Nov-Dec; 29(6); p. 312-21
Evidence for systems-level molecular mechanisms of tumorigenesis
Hernandez P; Huerta-Cepas J; Montaner D; Al-Shahrour F; Valls J; Gomez L; Capella G; Dopazo J; Pujana MA
BMC genomics; 2007 Jun 20; 8; p. 185
Health-related quality of life in multiple system atrophy
Schrag A; Geser F; Stampfer-Kountchev M; Seppi K; Sawires M; Kollensperger M; Scherfler C; Quinn N; Pellecchia MT; Barone P; Del Sorbo F; Albanese A; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Nilsson CF; Widner H; Lindvall O; Giladi N; Gurevich T; Dan
Movement disorders; 2006 Jun; 21(6); p. 809-15
Increase in body weight after pramipexole treatment in Parkinson's disease.
Kumru H; Santamaria J; Valldeoriola F; Marti MJ; Tolosa E
Movement disorders 2006 Nov; 21(11); p. 1972-4
Individual-based model and simulation of Plasmodium falciparum infected erythrocyte in vitro cultures
Ferrer J; Vidal J; Prats C; Valls J; Herreros E; Lopez D; Giro A; Gargallo D
Journal of theoretical biology; 2007 Oct 7; 248(3); p. 448-59
Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke
Chamorro A; Amaro S; Vargas M; Obach V; Cervera A; Torres F; Planas AM
Journal of neurology, neurosurgery, and psychiatry; 2006 Nov; 77(11); p. 1279-81
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance
Gaig C; Ezquerra M; Marti MJ; Munoz E; Valldeoriola F; Tolosa E
Archives of neurology; 2006 Mar; 63(3); p. 377
Management of paraneoplastic neurological syndromes: report of an EFNS Task Force
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R
European journal of neurology; 2006 Jul; 13(7); p. 682-90
Modest MRI signal intensity changes precede delayed cortical necrosis after transient focal ischemia in the rat
Rojas S; Martin A; Justicia C; Falcon C; Bargallo N; Chamorro A; Planas AM
Stroke; a journal of cerebral circulation; 2006 Jun; 37(6); p. 1525-32
Neuro-oncology: setting new standards of management
Graus F; Tortosa A Lancet neurology; 2006 Jan; 5(1); p. 8-9
Neuropsychological deficits in Parkinson's disease patients with visual hallucinations
Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
Movement disorders; 2006 Sep; 21(9); p. 1483-7
No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis
Blanco Y; Gomez-Choco M; Arostegui JL; Casanova B; Martinez-Rodriguez JE; Bosca I; Munteis E; Yague J; Graus F; Saiz A
Neuroscience letters; 2006 Apr 3; 396(3); p. 217-9
38
No evidence of CRHR1 gene involvement in progressive supranuclear palsy
Campdelacreu J; Gaig C; Ezquerra M; Munoz E; Marti MJ; Valldeoriola F; Tolosa E
Neuroscience letters; 2006 Nov 27; 409(1); p. 61-4
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)
Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Ostergaard K; Dupont E; Schimke N; Eggert KM; Oe
Movement disordersy; 2006 Feb; 21(2); p. 179-86
Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer
Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz ML; Saiz A; Benyahia B; Dalmau J; Graus F
Journal of neurology, neurosurgery, and psychiatry; 2006 Dec; 77(12); p. 1359-62
Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis
Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar C; Martinez-Rodriguez JE; Vincent A; Santamaria J
Annals of neurology; 2006 Jan; 59(1); p. 178-81
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study
Iranzo A; Molinuevo JL; Santamaria J; Serradell M; Marti MJ; Valldeoriola F; Tolosa E
Lancet neurology; 2006 Jul; 5(7); p. 572-7
Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode
Pintor L; Bailles E; Valldeoriola F; Tolosa E; Marti MJ; de Pablo J
General hospital psychiatry; 2006 Jan-Feb; 28(1); p. 59-64
Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease
Lees AJ; Ratziu V; Tolosa E; Oertel WH Journal of neurology, neurosurgery, and psychiatry; 2007 Sep; 78(9); p. 944-8
The alpha-synuclein gene in multiple system atrophy
Ozawa T; Healy DG; Abou-Sleiman PM; Ahmadi KR; Quinn N; Lees AJ; Shaw K; Wullner U; Berciano J; Moller JC; Kamm C; Burk K; Josephs KA; Barone P; Tolosa E; Goldstein DB; Wenning G; Geser F; Holton JL; Gasser T; Revesz T; Wood NW
Journal of neurology, neurosurgery, and psychiatry; 2006 Apr; 77(4); p. 464-7
The harms and benefits of inflammatory and immune responses in vascular disease
Chamorro A; Hallenbeck J Stroke; a journal of cerebral circulation; 2006 Feb; 37(2); p. 291-3
Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Romanos E; Planas AM; Amaro S; Chamorro A Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism; 2007 Jan; 27(1); p. 14-20
WAERS: an application for Web-assisted estimation of relative survival
Cleries R; Valls J; Esteban L; Galvez J; Pareja L; Sanz X; Alliste L; Martinez JM; Moreno V; Bosch X; Borras JM; Ribes JM
Medical informatics and the Internet in medicine; 2007 Sep; 32(3); p. 169-75
Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation
Martin A; Rojas S; Chamorro A; Falcon C; Bargallo N; Planas AM;
Stroke; a journal of cerebral circulation; 2006 May; 37(5); p. 1288-95
Revisió Dystonia in Parkinson's disease Tolosa E; Compta Y Journal of neurology; 2006 Dec; 253
Suppl 7; p. VII7-13 Immediate anticoagulation for acute stroke in atrial fibrillation: yes
Chamorro A Stroke; a journal of cerebral circulation; 2006 Dec; 37(12); p. 3052-3
39
Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European Union perspective
Serratosa J; Blass A; Rigau B; Mongrell B; Rigau T; Tortades M; Tolosa E; Aguilar C; Ribo O; Balague J
Revue scientifique et technique (International Office of Epizootics); 2006 Aug; 25(2); p. 637-53
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease
Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen JP; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C
European journal of neurology; 2006 Nov; 13(11); p. 1186-202
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen JP; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C
European journal of neurology; 2006 Nov; 13(11); p. 1170-85
Signalling pathways mediating inflammatory responses in brain ischaemia
Planas AM; Gorina R; Chamorro A Biochemical Society transactions; 2006 Dec; 34(Pt 6); p. 1267-70
The diagnosis of Parkinson's disease
Tolosa E; Wenning G; Poewe W Lancet neurology; 2006 Jan; 5(1); p. 75-86
Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells
Melms A; Luther C; Stoeckle C; Poschel S; Schroth P; Varga M; Wienhold W; Tolosa E
Acta neurologica Scandinavica Supplementum; 2006; 183; p. 12-3
Cas clínic de Andres C; Esquivel A; de Villoria JG; Graus F; Sanchez-Ramon S
de Andres C; Esquivel A; de Villoria JG; Graus F; Sanchez-Ramon S
Journal of neurology, neurosurgery, and psychiatry; 2006 Apr; 77(4); p. 562-3
MM1 variant of sporadic Creutzfeldt-Jakob disease with long duration akinetic mutism state
Sanchez-Valle R; Santamaria J; Rey MJ; Rodriguez A; Graus F; Saiz A
Neurologia (Barcelona, Spain); 2006 Oct; 21(8); p. 444-6
NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases
Zuliani L; Lopez de Munain A; Ruiz Martinez J; Olascoaga J; Graus F; Saiz A
Neurologia (Barcelona, Spain); 2006 Jul-Aug; 21(6); p. 314-7
Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies
Hernandez-Echebarria L; Saiz A; Ares A; Tejada J; Garcia-Tunon L; Nieves C; Graus F
Neurology; 2006 Feb 14; 66(3); p. 450-1
Pure autonomic failure with altered dopamine transporter imaging
Compta Y; Marti MJ; Paredes P; Tolosa E Archives of neurology; 2006 Apr; 63(4); p. 604
Carta Cognitive changes in Parkinson's disease during subthalamic stimulation: a clinicopathologic study
Valldeoriola F; Tolosa E; Alegret M; Tolosa E; Rey MJ; Morsi O; Pilleri M; Rumia J
Journal of neurology, neurosurgery, and psychiatry; 2006 Apr; 77(4); p. 565-6
Hu-antibody-positive patients with or without cancer have similar clinical profiles
Llado A; Carpentier AF; Honnorat J; Sillevis-Smitt P; Twijnstra A; Blanco Y; Hart IK; Saiz A; Graus F
Journal of neurology, neurosurgery, and psychiatry; 2006 Aug; 77(8); p. 996-7
40
Intronic c.573 + 79G>A polymorphism of protein Z gene in haemorrhagic and ischaemic stroke
Obach V; Munoz X; Sala N; Garcia de Frutos P; Chamorro A
Thrombosis and haemostasis; 2006 Jun; 95(6); p. 1040-1
Malalties Infeccioses
Malalties Infeccioses - Publicacions 2006 Titol Autors Cita Original A prospective survey of Human Herpesvirus-6 primary infection in solid organ transplant recipients
Cervera C, Marcos MA, Linares L, Roig E, Benito N, Pumarola T, Moreno A
Transplantation. 2006;82:979-982
A Review of Critical Periods for Opportunistic Infection in the New Transplantation Era
R San Juan Garrido, JM Aguado, C Diaz-Pedroche, O len, M Montejo, A Moreno, M Gurguí, J Torres-Cisneros, F Pareja, J Segovia, M García, C Lumbreras
Transplantation 2006; 82: 1457-1462
An integral care telemedicine system for HIV/AIDS patients.
Caceres C; Gomez EJ; Garcia F; Gatell JM; del Pozo F
International journal of medical informatics; 2006 Sep; 75(9); p. 638-42
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations
Blanco JL; Biglia A; De Lazzari E; Mallolas J; Martinez E; Pumarola T; Larrousse M; Milinkovic A; Leon A; Lonca M; Laguno M; Gatell JM
AIDS (London, England); 2006 Sep 11; 20(14); p. 1891-2
Antiretroviral therapy of HIV infection: duration and reasons for changing the first therapeutic regimen in 518 patients
Gratacos L; Tuset M; Codina C; Miro JM; Mallolas J; Miserachs N; Martin-Conde MT; del Cacho E; Lazzari E; Ribas J; Gatell JM
Medicina clinica; 2006 Feb 25; 126(7); p. 241-5
Aorto-Cavitary Fistula in Endocarditis Working Group. Periannular complications in infective endocarditis involving native aortic valves
Anguera I, Miro JM, Evangelista A, Cabell CH, San Roman JA, Vilacosta I, Almirante B, Ripoll T, Farinas MC, Anguita M, Navas E, Gonzalez-Juanatey C, Garcia-Bolao I, Munoz P, de Alarcon A, Sarria C, Rufi G, Miralles F, Pare C, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR, Moreno A et al.
Am J Cardiol. 2006 Nov 1;98(9):1254-60
Aorto-Cavitary Fistula in Endocarditis Working Group. Periannular complications in infective endocarditis involving prosthetic aortic valves
Anguera I, Miro JM et al. Am J Cardiol. 2006 Nov 1;98(9):1261-8
Behcet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy
Gomez-Puerta JA, Espinosa G, Miro JM, Sued O, Llibre JM, Cervera R, Font J
Isr Med Assoc J. 2006 Jul;8(7):513-4
Cardiac surgery in human immunodeficiency virus positive patients
Mestres CA, Miro JM Ind J Thorac Cardiovasc Surg. 2006; 22:203-204
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002
Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
Archives of internal medicine; 2006 Mar 13; 166(5); p. 521
Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naive patients starting cART after January 1, 2000
Gatell JM, Miro JM, Zamora L HIV Clin Trials. 2006 Nov-Dec;7(6):271-84
41
Complications of Native and Prosthetic Valve Infective Endocarditis: Update in 2006
Anguera I, Del Rio A, Moreno A, Pare C, Mestres CA, Miro JM
Curr Infect Dis Rep. 2006 Jun;8(4):280-8
Complications of Native andProsthetic Valve Infective Endocarditis: Update in 2006
Anguera I; Del Rio A; Moreno A; Pare C; Mestres CA; Miro JM
Current infectious disease reports; 2006 Jun; 8(4); p. 280-8
Cryopreserved mitral homograft in the tricuspid position for infective endocarditis: a valve that can be repaired in the long-term (13 years)
Mestres CA, Castella M, Moreno A, Pare JC, del Rio A, Azqueta M, Fernandez C, Miro JM, Pomar JL
J Heart Valve Dis. 2006 May;15(3):389-91
Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART.
Coll O; Suy A; Figueras F; Vernaeve V; Martinez E; Mataro D; Durban M; Lonca M; Vidal R; Gatell JM
AIDS (London, England); 2006 Jan 2; 20(1); p. 121-3
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial
Miro JM, Lopez JC, Podzamczer D, Pena JM, Alberdi JC, Martinez E, Domingo P, Cosin J, Claramonte X, Arribas JR, Santin M, Ribera E; GESIDA 04/98 Study Group
Clin Infect Dis. 2006 Jul 1;43(1):79-89
Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.
Libois A; Lopez A; Garcia F; Castro P; Maleno MJ; Garcia A; Climent N; Arnedo M; Gallart T; Gatell JM; Plana M
AIDS research and human retroviruses;2006 Jul; 22(7); p. 657-66
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort
Berenguer J; Perez-Elias MJ; Bellon JM; Knobel H; Rivas-Gonzalez P; Gatell JM; Miguelez M; Hernandez-Quero J; Flores J; Soriano V; Santos I; Podzamczer D; Sala M; Camba M; Resino S;
Journal of acquired immune deficiency syndromes (1999); 2006 Feb 1; 41(2); p. 154-9
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonca J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA
HIV medicine; 2006 Apr; 7(3); p. 146-55
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study
Gatell JM, Miro JM, Zamora L J Infect Dis. 2006 Sep 1;194(5):633-41
Glutamate released by dendritic cells as a novel modulator of T cell activation
Pacheco R; Oliva H; Martinez-Navio JM; Climent N; Ciruela F; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
Journal of immunology (Baltimore, Md : 1950); 2006 Nov 15; 177(10); p. 6695-704
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Sierra JM; Sanchez F; Castro P; Salvado M; de la Red G; Libois A; Almela M; March F; Espanol M; Sambeat MA; Romeu J; Brugal MT; Garcia de Olalla P; Gatell JM; Vila J; Garcia F; Lopez Colomes JL; Cayla JA; Coll P
Medicine; 2006 May; 85(3); p. 139-46
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
Gatell JM, Miro JM, Zamora L Lancet. 2006 Aug 5;368(9534):451-8
42
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.
Suy A; Martinez E; Coll O; Lonca M; Palacio M; de Lazzari E; Larrousse M; Milinkovic A; Hernandez S; Blanco JL; Mallolas J; Leon A; Vanrell JA; Gatell JM
AIDS (London, England); 2006 Jan 2; 20(1); p. 59-66
Influence of Diabetes Mellitus on the Clinical Manifestations and Prognosis of Infective Endocarditis: A report from the International Collaboration on Endocarditis. Merged Database
Kourany, W., Miró J., Moreno A., Corey R., Pappas P., Abrutyn E., Hoen B., Habib G., Fowler V., Sexton D., Olaison L., Cabell C
Scand J Infect Dis. 2006; 38: 613-619
Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database
Kourany WM, Miro JM, Moreno A et al Scand J Infect Dis. 2006;38(8):613-9
Intrathoracic fat in HIV-infected patients.
Blanco JL; Biglia A; Martinez E; Sanchez M; de Lazzari E; Leon A; Milinkovic A; Larrousse M; Lonca M; Laguno M; Mallolas J; Gatell JM
HIV medicine; 2006 May; 7(4); p. 213-7
Liver Transplantation in HIV-Infected Patients: Update in 2006
Miró JM, Murillas J, Laguno M, Tuset M, Agüero F, Moreno A, Rimola A and the Hospital Clinic OLT in HIV Working Group
Hepatology Rev. 2006;3:16-29
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
Gatell JM, Miro JM, Zamora L Arch Intern Med. 2006 Aug 14-28;166(15):1632-41
Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?
Miro JM, Laguno M, Moreno A, Rimola A and the Hospital Clinic OLT in HIV Working Group
J Hepatol. 2006;44(1 Suppl):S140-5
Microbiologic features and outcome of pneumonia in transplanted patients
C Cervera, C Agustí, MA Marcos, T Pumarola, F Cofán, M Navasa, F Perez-Villa, Antonio Torres, AMoreno
Diag Microbiol Infect Dis. 2006;55(1):47-54
Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study
Jimenez-Exposito MJ, Mestres CA, Claramonte X, Cartana R, Josa M, Pomar JL, Mulet J, Miro JM; en representacion del Grupo de Estudio de Endocarditis del Hospital Clinic-IDIBAPS
Rev Esp Cardiol. 2006 Mar;59(3):276-9
Periannular Complications in Infective Endocarditis Involving Native Aortic Valves
Anguera I., Miro JM., Evangelista A., Cabell C., San Roman JA., Vilacosta I., Almirante B., Ripoll T., Fariñas MC., Anguita M., Navas E., Gonzalez-Juanatey C., Garcia-Bolao I., Muñoz P., de Alarcón A., Sarriá C., Rufi G., Miralles F., Pare C., Fowler V., Mestres CA., de Lazzari E., Guma JR., Moreno A., Corey GR and the Aorto-Cavitary Fistula in Endocarditis Working Group
Am J Cardiol 2006; 98: 1254-1260
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
Sued O; Miro JM; Alquezar A; Claramonte X; Garcia F; Plana M; Arnedo M; de Lazzari E; Gil C; Manzardo C; Blanco JL; Martinez E; Mallolas J; Joseph J; Pumarola T; Gallart T; Gatell JM
Enfermedades infecciosas y microbiologia clinica; 2006 Apr; 24(4); p. 238-44
Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guerin: failures and challenges.
Joseph J; Saubi N; Pezzat E; Gatell JM; Expert review of vaccines; 2006 Dec; 5(6); p. 827-38
43
Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies
Gatell JM, Miro JM, Zamora L J Infect Dis. 2006 Sep 1;194(5):612-22
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe
Gatell JM, Miro JM, Zamora L J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-37
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.
Bannister WP; Kirk O; Gatell JM; Knysz B; Viard JP; Mens H; Monforte AD; Phillips AN; Mocroft A; Lundgren JD
Journal of acquired immune deficiency syndromes (1999); 2006 Jun; 42(2); p. 229-37
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia
Gatell JM, Miro JM, Zamora L AIDS 2006 May 12;20(8):1141-50
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials
Lifson AR; Rhame FS; Belloso WH; Dragsted UB; El-Sadr WM; Gatell JM; Hoy JF; Krum EA; Nelson R; Pedersen C; Pett SL; Davey RT Jr;
HIV clinical trials; 2006 May-Jun; 7(3); p. 125-41
Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens
Alvarez-Martinez MJ; Miro JM; Valls ME; Moreno A; Rivas PV; Sole M; Benito N; Domingo P; Munoz C; Rivera E; Zar HJ; Wissmann G; Diehl AR; Prolla JC; de Anta MT; Gatell JM; Wilson PE; Meshnick SR and the Spanish PCP Working Group
Diagnostic microbiology and infectious disease; 2006 Oct; 56(2); p. 153-60
Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion.
Naranjo-Gomez M; Climent N; Cos J; Oliva H; Bofill M; Gatell JM; Gallart T; Pujol-Borrell R; Borras FE
Immunology; 2006 Dec; 119(4); p. 488-98
The cryopreserved mitral homograft in the tricuspid position for infective endocarditis
Carlos-A Mestres, Manuel Castellá, Asunción Moreno, J.Carlos Paré, Ana del Rio, Manuel Azqueta, Claudio Fernández, José Mª Miró, José Luis Pomar and the Hospital Clínic Endocarditis Study Group
J Heart Valve Dis.. 2006 May;15(3):389-91
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era
Gatell JM, Miro JM, Zamora L Clin Trials. 2006;3(2):119-32
The International Collaboration on Endocarditis Merged Database Study Group. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database
Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, Woods CW, Cabell CH, Hoen B, Selton-Suty C, Doco-Lecompte T, Chirouze C, Raoult D, Miro JM et al.
Eur J Clin Microbiol Infect Dis. 2006 Jun;25(6):365-8
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study
Gatell JM, Miro JM, Zamora L HIV Med. 2006 May;7(4):218-30
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section
Mallolas J; Arnedo M; Pumarola T; Erice A; Blanco JL; Martinez E; Gatell JM
AIDS (London, England); 2006 Jan 9; 20(2); p. 285-7
44
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel
Hammer SM; Saag MS; Schechter M; Montaner JS; Schooley RT; Jacobsen DM; Thompson MA; Carpenter CC; Fischl MA; Gazzard BG; Gatell JM; Hirsch MS; Katzenstein DA; Richman DD; Vella S; Yeni PG; Volberding PA
Topics in HIV medicine : a publication of the International AIDS Society, USA; 2006 Aug-Sep; 14(3); p. 827-43
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
Hammer SM; Saag MS; Schechter M; Montaner JS; Schooley RT; Jacobsen DM; Thompson MA; Carpenter CC; Fischl MA; Gazzard BG; Gatell JM; Hirsch MS; Katzenstein DA; Richman DD; Vella S; Yeni PG; Volberding PA
JAMA : the journal of the American Medical Association; 2006 Aug 16; 296(7); p. 827
Revisió ¿Podemos mejorar el pronóstico de la endocarditis estafilocócica?
del Río A, Miró JM Enferm Infecc Microbiol Clin. 2006; 5(3):58-70
Complications of Native and Prosthetic Valve Infective Endocarditis: Update in 2006
Anguera I, Del Rio A, Moreno A, Pare C, Mestres CA, Miro JM
Curr Infect Dis Rep. 2006 Jun;8(4):280-8
Enfermedades Infecciosas y Microbiología Clínica: actividad editorial 2002-2005
Almirante B, Alonso J, Martinez-Martinez L, Miro JM, Pascual A
Enferm Infecc Microbiol Clin. 2006; 24(3):143-146
Infections due to HIV-2 and HTLV-1/2 in Spain
Toro C, Soriano V; Grupo Espanol de Estudio del VIH-2 y HTLV-1/2 (Miro JM, Sued O, Hosp. Clinic. Barcelona, Spain)
Enferm Infecc Microbiol Clin. 2006 Oct;24(8):481-2
Interacciones de los fármacos antirretrovirales: actualización
Tuset M, Miro JM, Carcelero E, Sarasa M, Codina C, Ribas J
Infecciones e Inmunología. 2006; 5 (2): 18-43
Management of end stage liver disease (ESLD): What is the current role of orthotopic liver tranbsplantation (OLT)?
JM Miró, M Laguno, A Moreno, A Rimola, the Hospital Clínic OLT in VIH Working Group
Journal of Hepatology. 2006; 44; S140-5
Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (Update January 2007)
Miro JM, Enferm Infecc Microbiol Clin. 2007 Jan;25(1):32-53
Carta Antiretroviral therapy in patients with primary HIV infection
Sued O, Iribarren JA, Arrizabalaga J, Miro JM Med Clin (Barc). 2006 Feb 4;126(4):157
Antiretroviral treatment in patient with advanced immunosuppression
Arribas JR, Pulido F, Gonzalez-Garcia JJ, Miro JM Med Clin (Barc). 2006 Feb 4;126(4):157-8
Considerations about the value of sonography for the measurement of regional body fat.
Martinez E; Milinkovic A; Bianchi L; Gatell JM AIDS (London, England); 2006 Feb 14; 20(3); p. 465-6
Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia
Garrabou G; Sanjurjo E; Miro O; Martinez E; Infante AB; Lopez S; Cardellach F; Gatell JM; Casademont J
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; 2006 Feb 15; 42(4); p. 584-5
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section
Mallolas J; Gatell JM; Bruguera M AIDS (London, England); 2006 Aug 22; 20(13); p. 1785
Llibre Guía de bolsillo de interacciones farmacológicas en VIH
Tuset M, Miró JM, Codina C, Ribas J Sexta edición. Madrid. SiCom XXI SL. 2006 Depósito legal: M-38896-2006
Resumen Científico ICAAC-2006 Arribas JR, Miró JM, Rodríguez JL, De la Torre J (Eds)
Octaba Edición. Barcelona. Ediciones Permanyer. 2006. ISBN: 84-935225-4-6
Capítol llibre
45
Endocarditis infecciosa sobre válvula nativa.
Miró JM, Tornos P, Fernández-Guerrero ML En: Tratado SEIMC de Patología Infecciosa. Ausina V, Moreno S (Ed.). Segunda edición: Capítulo 132. Buenos Aires-Madrid: Editorial Médica Panamericana SA. 2006: 1293-1313
Farmacocinética e interacciones de tripanavir
Tuset M, Gratacòs L, Codina C, Miró JM Gatell JM, Mensa J y Zamora L (Eds). Tripinavir el Inhibidor de la proteasa de una generación. Capítulo 6. Barcelona. Editorial Antares, SCP . 2006: 107-143
Infección aguda por el VIH, tratamiento antirretroviral (TARV) inicial, paradas del TARV, terapias inmunomediadas y profilaxis postexposición accidental
Miró JM Arribas JR, Miró JM, Rodríguez JL, De la Torre Cisneros J (Eds).Resumen Científico ICAAC 2005. 7ª Edición. Barcelona. Ediciones P. Permanyer. 2006:55-62
Infección aguda por el VIH, tratamiento antirretroviral (TARV) inicial, paradas del TARV, terapias inmunomediadas y profilaxis postexposición accidental (PEP)
Miró JM Arribas JR, Miró JM, Rodríguez JL, De la Torre Cisneros J (Eds).Resumen Científico ICAAC 2006. 8ª Edición. Barcelona. Ediciones Permanyer. 2006:67-75
Infecciones producidas por el grupo Herpes (no VIH, no trasplante) y otros virus
Fortún J, Moreno A En: Resumen Científico ICAAC-2006. Barcelona, Ediciones Permanyer SL. 2006:107-13
Liver transplantation in HIV-infected patients
Miró JM, Agüero F, Murillas J, Laguno M, Tuset M, Moreno A, Rimola A
Mallolas J (Ed). HCV-HIV coinfection. Chapter 5. Barcelona. Editorial P. Permanyer. 2006: 109-126
Profilaxis y tratamiento de las infecciones oportunistas en los pacientes con Sid
Sued O, García F, Miró JM García JE, Gobernado M, Picazo JJ, Prieto J (Eds). Antimicrobianos en Medicina. 2ª Edición. Capítulo 50. Barcelona. Editorial Prous Science, SA. 2006: 641-654
Tratamiento de la infección por el virus de la inmunodeficiencia humana
Mallolas J, Miró JM, Gatell J García JE, Gobernado M, Picazo JJ, Prieto J (Eds). Antimicrobianos en Medicina. 2ª Edición. Capítulo 49. Barcelona. Editorial Prous Science, SA. 2006: 633-640
Truvada un fármaco esencial en el tratamiento inicial. Capítulo 3
Diego E, Fontanals S, Tuset M, Martín M, Miró JM Farmacocinética e interacciones farmacocinéticas de Truvada ®. Gatell JM, Mensa J y Zamora L (Eds). Barcelona. Editorial Antares, SCP. 2006: 33-68
Malalties Infeccioses - Projectes de recerca finançats 2006 Investigador
Principal Referència Ajut Entitat Nom Projecte Import Durada
Gatel JM ? Fundación Mútua Madrileña
Construcción de una vacuna contra el virus de la inmunodeficiencia humana tipo 1 basada en BCG y virus vaccinia
65.000 2005-2008
Gatell JM SAFR2005-05566 ? Estudio de la respuesta inmunitaria in vitro a una vacuna terapñeutica contra el VIH-1 reparada con células dendríticas mieloides autólogas pulsadas con diferentes inmunogenos
80.000,00 2005-2008
Gatell JM ? Concerted Action European Union. Program Biomed 2
Eurosida ? 2004-2006
Gatell JM safr2005-05566 ? Estudio de la respuesta inmunitaria in vitro a una vacuna terapéutica contra el VIH-1 reparada con células dendríticas micloides autólogas pulsadas con diferentes inmunógenos.
80.000 2005-2008
Gatell JM ? Fundación Mútua Construcción de unaq vacuna contra el virus de la 65.000 2005-2008
46
Madrileña inmunodeficiencia humana tipo I basada en BCG y virus vaccinia.
Gatell JM ? Proyecto Orvacs Vacunas terapéuticas contra el VIH ? 2004-2006 Gatell JM FIS 050130 Ministerio Sanidad y
Consumo Proyectos coordinados en epidemiología, investigación básica y clínica de la red de investigación en SIDA (Ris) para el año 2006.
53.550 2006
Miro JM PI 040363 FIS Fondo Investigacion Sanitaria
Estudio piloto del tratamiento inmunomediado de la infección aguda por el VIH con el fin de inducir una fuerte respuesta inmunoespecífica frente al VIH que permita el control de la replicación viral sin tratamiento retroviral (TARV)
148.925 2005-2007
Miro JM TOH/VIH-05 FIPSE Estudio FIPSE de trasplante hepático en pacientes infectados por el VIH en España. Estudio Gesida 45-05
571.359,8 2005-2008
Moreno MA ? Mútua Automovilística Madrileña
Investigación en el trasplante 60.000 2004-2006
Moreno MA FIS PI050315 Fondo Investigacion Sanitaria
Infección y trasplante. Consolidación de RESITRA en el marco RETICS. Explotación de la cohorte RESITRA
20.349 2006
Malalties Reumatològiques i del Sistema Immune
Malalties Reumatològiques i del Sistema Immune - Publicacions 2006 Títol Autors Cita Original Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behcet's disease
Muñoz-Saa I, Cambra A, Pallares L, Espinosa G, Juan A, Pujalte F, Matamoros N, Mila J, Julia MR
Scand J Immunol 2006; 64: 77-82
Anti-inflammatory and immunosuppressive drugs and reproduction
Ostensen M; Khamashta M; Lockshin M; Parke A; Brucato A; Carp H; Doria A; Rai R; Meroni P; Cetin I; Derksen R; Branch W; Motta M; Gordon C; Ruiz-Irastorza G; Spinillo A; Friedman D; Cimaz R; Czeizel A; Piette JC; Cervera R; Levy RA; Clementi M; De Caroli
Arthritis research & therapy; 2006; 8(3); p. 209
Antiphospholipid antibodies associated with malignancies: Clinical and pathological characteristics of 120 patients
Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J
Semin Arthritis Rheum 2006; 35: 322-32
Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases
Ramos-Casals M; Nardi N; Brito-Zeron P; Aguilo S; Gil V; Delgado G; Bove A; Font J
Seminars in arthritis and rheumatism; 2006 Apr; 35(5); p. 312-21
Autoantibodies and prediction of reproductive failure
Shoenfeld Y; Carp HJ; Molina V; Blank M; Cervera R; Balasch J; Tincani A; Faden D; Lojacono A; Doria A; Konova E; Meroni PL
American journal of reproductive immunology (New York, N.Y : 1989); 2006 Nov-Dec; 56(5-6); p. 337-44
Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement
Peris P, Alvarez L, Vidal S, Kasper D, Leeming DJ, Monegal A, Angeles Martinez M, Pons F, Guanabens N
Calcif Tissue Int. 2006 Jul;79(1):22-6
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment
Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S, Guanabens N, Migone N, Wientroub S, Divizia MT, Bergmann C, Bennett C, Simsek S, Melancon S, Cundy T, Van Hul W
J Med Genet. 2006 Jan;43(1):1-11
Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis
Gomez-Puerta JA; Salgado E; Cervera R; Aguilo S; Ramos-Casals M; Soler M; Torras A; Font J
Clinical and experimental rheumatology; 2006 Jan-Feb; 24(1); p. 110
47
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome
Ramos-Casals M, Sanchez-Tapias JM, Pares A, Forns X, Brito-Zeron P, Nardi N, Vazquez P, Velez D, Arias I, Bove A, Plaza J, Rodes J, Font J
J Rheumatol 2006; 33: 1593-9
Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients
Nardi N; Brito-Zeron P; Ramos-Casals M; Aguilo S; Cervera R; Ingelmo M; Font J
Clinical rheumatology; 2006 May; 25(3); p. 341-6
Epidemiology of systemic lupus erythematosus at the change of the millennium: lessons from the Euro-Lupus and the LUMINA projects
Cervera R; Khamashta MA Lupus; 2006; 15(1); p. 1-2
European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders
Wiik A; Cervera R; Haass M; Kallenberg C; Khamashta M; Meroni PL; Piette JC; Schmitt R; Shoenfeld Y
Lupus; 2006; 15(7); p. 391-6
Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications
Carmona F; Lazaro I; Reverter JC; Tassies D; Font J; Cervera R; Balasch J
American journal of obstetrics and gynecology; 2006 Feb; 194(2); p. 457-65
Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients
Bosch X; Guilabert A; Pallares L; Cerveral R; Ramos-Casals M; Bove A; Ingelmo M; Font J
Lupus; 2006; 15(9); p. 584-9
Inhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group
Sosa M, Saavedra P, Valero C, Guanabens N, Nogues X, del Pino-Montes J, Mosquera J, Alegre J, Gomez-Alonso C, Munoz-Torres M, Quesada M, Perez-Cano R,GIUMO Study Group
Journal of Clinical Densitometry 2006;9:154-8
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA
Journal of thrombosis and haemostasis : JTH; 2006 Feb; 4(2); p. 295-306
Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases
Ramos-Casals M, Robles A, Brito-Zeron P, Nardi N, Nicolas JM, Forns X, Plaza J, Yague J, Sanchez-Tapias JM, Font J
Semin Arthritis Rheum 2006; 36: 189-96.
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients
Bucciarelli S; Espinosa G; Cervera R; Erkan D; Gomez-Puerta JA; Ramos-Casals M; Font J; Asherson RA
Arthritis and rheumatism; 2006 Aug; 54(8); p. 2568-76
nhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group
Jodar E, Torrijos A, Lozano-Tonkin C, Diaz-Curiel M, GIUMO Study Group
J Clin Densitom. 2006 Apr-Jun;9(2):154-8
Resultados del tratamiento con pilocarpina oral en 100 pacientes con síndrome de Sjögren primario
Brito-Zerón P, Ramos-Casals M, Nardi N, Font J
Med Clin (Barc) 2006; 126: 637
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients
Bucciarelli S; Espinosa G; Asherson RA; Cervera R; Claver G; Gomez-Puerta JA; Ramos-Casals M; Ingelmo M
Annals of the rheumatic diseases; 2006 Jan; 65(1); p. 81-6
Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients
Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zeron P; Bove A; Delgado G; Cervera R; Ingelmo M; Font J
Medicine; 2006 Mar; 85(2); p. 95-104
Revisió Anti-chromatin (anti-nucleosome) antibodies
Gomez-Puerta JA; Burlingame RW; Cervera R Lupus; 2006; 15(7); p. 408-11
48
Antineutrophil cytoplasmic antibodies
Bosch X; Guilabert A; Font J Lancet; 2006 Jul 29; 368(9533); p. 404
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients
Gomez-Puerta JA; Cervera R; Espinosa G; Aguilo S; Bucciarelli S; Ramos-Casals M; Ingelmo M; Asherson RA; Font J
Seminars in arthritis and rheumatism; 2006 Apr; 35(5); p. 322-3295-104
Catastrophic antiphospholipid syndrome
Cervera R; Asherton RA Pathophysiology of haemostasis and thrombosis; 2006; 35(1-2); p. 181-6
Catastrophic antiphospholipid syndrome
Cervera R; Asherson RA; Font J Rheumatic diseases clinics of North America; 2006 Aug; 32(3); p. 575-90
European Working Party on Systemic Lupus Erythematosus: a 15-year report
Cervera R; Font J; Shoenfeld Y Autoimmunity reviews; 2006 Oct; 5(8); p. 549-53
Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease
Escarcega RO; Garcia-Carrasco M; Fuentes-Alexandro S; Jara LJ; Rojas-Rodriguez J; Escobar-Linares LE; Cervera R
Autoimmunity reviews; 2006 Nov; 6(1); p. 48-53
Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome
Espinosa G; Bucciarelli S; Cervera R; Gomez-Puerta JA; Font J
Autoimmunity reviews; 2006 Dec; 6(2); p. 68-71
Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry
Cervera R; Espinosa G; Bucciarelli S; Gomez-Puerta JA; Font J
Autoimmunity reviews; 2006 Dec; 6(2); p. 81-4
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors
Bucciarelli S; Cervera R; Espinosa G; Gomez-Puerta JA; Ramos-Casals M; Font J
Autoimmunity reviews; 2006 Dec; 6(2); p. 72-5
Pathophysiology of Sjogren's syndrome
Garcia-Carrasco M; Fuentes-Alexandro S; Escarcega RO; Salgado G; Riebeling C; Cervera R
Archives of medical research; 2006 Nov; 37(8); p. 921-32
Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome
Gomez-Puerta JA; Cervera R; Espinosa G; Bucciarelli S; Font J
Autoimmunity reviews; 2006 Dec; 6(2); p. 85-8
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project"
Cervera R; Abarca-Costalago M; Abramovicz D; Allegri F; Annunziata P; Aydintug AO; Bacarelli MR; Bellisai F; Bernardino I; Biernat-Kaluza E; Blockmans D; Boki K; Bracci L; Campanella V; Camps MT; Carcassi C; Cattaneo R; Cauli A; Cervera R; Chwalinska-Sad
Autoimmunity reviews; 2006 Mar; 5(3); p. 180-6
The catastrophic antiphospholipid (Asherson's) syndrome and malignancies
Miesbach W; Asherson RA; Cervera R; Shoenfeld Y; Puerta JG; Bucciarelli S; Espinoza G; Font J
utoimmunity reviews; 2006 Dec; 6(2); p. 94-7
Treatment of bone disorders in liver disease
Pares A, Guanabens N J Hepatol. 2006 Sep;45(3):445-53
Cas Clínic Behcet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy
Gomez-Puerta JA; Espinosa G; Miro JM; Sued O; Llibre JM; Cervera R; Font J
IMAJ; 2006 Jul; 8(7); p. 513-4
Bilateral tibial stress fracture presenting as painful edemas in lower limbs
Peris P, Monegal A, Martinez M, Guanabens N Joint Bone Spine. 2006;73:557-9
Fixed ceramometallic prostheses over anterior and transzygomatic implants by using the sinus slot technique--report of a case
Penarrocha-Diago M; Boronat A; Cervera R; Garcia B
The Journal of oral implantology; 2006; 32(1); p. 38-40
49
Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome
Mundo J; Peris P; Monegal A; Navasa M; Cervera R; Guaniabens N
Lupus; 2006; 15(5); p. 304-7
Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome
Mundo J, Peris P, Monegal A, Navasa M, Cervera R, Guañabens N
Lupus 2006;15:304:7
Editorial Infectious origin of the antiphospholipid syndrome
Shoenfeld Y; Blank M; Cervera R; Font J; Raschi E; Meroni PL
Annals of the rheumatic diseases; 2006 Jan; 65(1); p. 2-6
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?
Asherson RA; Cervera R; Shepshelovich D; Shoenfeld Y
The Journal of rheumatology; 2006 Jun; 33(6); p. 1038-44
Primary pulmonary arterial hypertension and the systemic autoimmune diseases
Cervera R; Asherson RA IMAJ; 2006 Apr; 8(4); p. 277-9
Carta Antiphospholipid antibody-associated thrombocytopenia and the paradoxical risk of thrombosis
Fortea J; Obach V; Cervera R; Gamarra AI Lupus; 2006; 15(1); p. 58
Antiphospholipid syndrome and minimal change nephropathy
Rossinol T; Cervera R; Lopez C; Sole M; Ramos-Casals M; Font J
Lupus; 2006; 15(8); p. 547-8
V meeting of the European forum on antiphospholipid antibodies
Cervera R; Font J; Tincani A; Boffa MC Autoimmunity reviews; 2006 Aug; 5(7); p. 499-507
Capítol Llibre Marcadores bioquímicos del recambio óseo en la evaluación de la enfermedad
Peris P, Alvarez L, Guañabens N En “Enfermedad Ósea de Paget. SCM eds, 2006; pp:71-80
Medicina d'Atenció Primària
Malalties d'Atenció Primària - Publicacions 2006 Títol Autors Cita Original Análisis de los estudios publicados sobre el incumplimiento terapéutico en la hipertensión arterial en España entre los años 1984 y 2005
Márquez E, Vil V, Casado JJ, Martell N, de la Figuera M, et al.
Aten Primaria 2006; 38:325-32
Malalties Reumatològiques i del Sistema Immune - Projectes de recerca finançats 2006
Inv. Principal Ref. Ajut Entitat Nom Projecte Import € Durada Cervera R PI 03/028
Ministerio
y Consumo Alteraciones genéticas en el funcionalismo plaquetario, la fibrinolisis y
ma inmunitario innato como factores predisponentes de arteriosclerosis en pacientes con lupus eritematoso sistémico
116.265
2003-2006
Guañabens N PI050044 FIS Estudio del efecto bifásico de la hormona paratiroidea (PTH) sobre stos humanos primarios en cultivo. Acción sobre el sistema OPG/RANKL rcadores de diferenciación osteoblástica RUNX2/CBFA1, osteocalcina y
geno tipo I
?? 2006-2008
50
Automedida de la presión arterial domiciliaria. Influencia del sistema de cáculo de la media en el diagnóstico de la Hipertensión de bata blanca
J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX Naberan, A. Botey
Aten Primaria 2006;38:212-8
Bacterial etiology of chronic bronchitis exacerbations treated by primary care physicians
Llor C; Cots JM; Herreras A Archivos de bronconeumologia; 2006 Aug; 42(8); p. 388-93
Consumo de fruta y verduras en la prevención del ictus. ¿Incide el consumo de frutas y verduras en el riesgo de presentar un ictus?
Coca A. Jano 2006; 1629:39-40
Effect of intervention promoting a reduction in antibiotic prescribing by improvement of a diagnostic procedures: a prospective, before and after study in general practice
Bjerrum L, Cots JM, Llor C, Molist N, Munck A Euro J Clin Pharmacol 2006; 62: 913-8
Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: a prospective, before and after study in general practice.
Bjerrum L; Cots JM; Llor C; Molist N; Munck A European journal of clinical pharmacology; 2006 Nov; 62(11); p. 913-8
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Gired X, Jamerson K, Larochelle P, MacDonald ThM, Schmieder RE, Schork MA, Stolf P, Viskoper R, Widimsky J, Zanchetti A, for the VALUE Trial Investigators
Journal of Hypertension 2006; 24: 1405-1412
Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study
Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, et al.
J Hypertens. 2006 Jan;24(1):169-75
Estimated risk of a first stroke and conditioning factors in Spanish hypertensive women. The RIMH study.
Coca A; Redon J; Cea-Calvo L; Lozano JV; Navarro J; Fernandez-Perez C; Bonet A; Gonzalez-Esteban J
Blood pressure; 2006; 15(4); p. 237-44
Estrategias para un control eficaz dela hipertensión arterial en España. Documento de consenso
Coca A; Aranda P; Bertomeu V; Bonet A; Esmatjes E; Guillen F; Hernandez-Moreno J; Llisterri JL; Marin-Iranzo R; Megia C; Rodriguez-Manas L; Suarez C;
Revista Clinica espanola; 2006 Nov; 206(10); p. 510-4
Etiología bacteriana de la agudización de la bronquitis crónica en atención primaria
Llor C, Cots JM , Herreras A Arch Bronconeumol. 2006; 42:388-9
Factores de riesgo de elevado coste de las agudizaciones de la bronquitis crónica y la EPOC
Llor C, Naberan K, Cots JM, Molina J, Ros F, Miravitlles M
Arch Bronconeumol 2006;42:175-82
Home blood presure self-monitoing: diagnostic performance in white-coat hypertension
J. Bayó, FX Cos, C. Roca, A. Dalfó, MM Martín-Baranera, A. Botey
Blood Presure Monitoring 2006; 11:47-52
Indicadores de calidad en unidades asistenciales de hipertensión arterial en España: indicadores de estructura en el estudio QUALITHA
Poch E, Felip A, Davins J, Coca A Revista Clínica Española 2006; 206: 541-8
Predictors of adverse outcome among patients with hypertension and coronary artery disease
Pepine CJ, Kowey PR, Kupfer S, Kollock RE, Benetos A, Mancia G, Coca A, Cooper-DeHoff RM, Handberg E, Gaxiola E, Sleight P, Conti CR, Hewkin AC, Tavazzi L, for the INVEST Investigators
Journal of the American College of Cardiology 2006; 7: 547-51
51
Reducción de la prescripción de antibióticos en la sinusitis mediante la realización de una auditoria
Llor C, CotsJM, Molist N, Boada A Aten Primaria 2006; 38:304-5
Rendiment diagnòstic de l’automesura se la pressió arterial domiciliària en la Hipertensió Clínica Aïllada
J. Bayó, C. Roca, A. Dalfó, MM Martín-Baranera, C. Medrano
Butlletí de la Societat Catalana de Medicina Familiar i Comunitària 2006; 24:14-20
Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease]
Llor C; Naberan K; Cots JM; Molina J; Ros F; Miravitlles M
Archivos de bronconeumologia; 2006 Apr; 42(4); p. 175-82
Tratamiento y control del riesgo cardiovascular en atención primaria en España. Estudio PREVENCAT.
Coca A; Dalfo A; Esmatjes E; Llisterri JL; Ordonez J; Gomis R; Gonzalez-Juanatey JR; Martin-Zurro A
Medicina clinica; 2006 Feb 18; 126(6); p. 201-5
Variabilidad de la prescripción antibiótica en las infecciones respiratorias en dos países de Europa
Llor C, Cots JM, Boada A, Bjerrum L, Gahrn-Hansen B, Munck A, et al
Enferm Infecc Microbiol Clin 2005; 23:598-604
Revisió Concerning World Heart Day Morales A, Coca A Revista Española de Cardiología 2006;
59:184 Efermedades importadas en inmigrantes: mito y realidad
C. Roca, X. Balanzó An Sist Sanit Nav 2006; 29 (supl 1):139-144
Enfoque conjunto de los factores de riesgo cardiovascular
De la Figuera M, Llisterri JL Med Clin (Barc) 2006; 127:774-5
Ensayos clínicos de morbimortalidad con calcioantagonistas en hipertensión.
De la Figuera M
Hipertensión 2006; 23 (extraord. 2); 20-7
Estrategias para un control eficaz de la hipertensión arterial en España. Documento de Consenso
Coca A, Aranda P, Bertomeu V; Bonet A, Esmatjes E, Guillén F, Hernández-Moreno J, Llisterri JL, Marín-Iranzo R, Megía C, Rodríguez-Mañas L, Suarez C
SEMERGEN 2006; 32: 30-3
Estudio ASCOT: prevención de eventos vasculares con diferentes combinaciones de fármacos antihipertensivos: la reducción de la presión arterial es lo que importa (en parte)
De la Figuera M Atención Primaria Basada en la Evidencia 2006; 1: 184
Importancia del control de la presión arterial en al reducción de la morbimortalidad cardiovascular
Coll de Tuero G, De la Figuera M Drugs Expert 2006. Adis. Madrid
Inhibidores de la renina De la Figuera M, Vinyoles E Hipertensión 2006; 23: 216-21 Leptina, obesidad e hipertensión arterial
Vidal J, Coca A Medicina Clinica (Barc) 2006; 126: 695-696
Carta Qualitative indicators in antibiotic prescription: Are they the most appropriate ones?
Llor C; Cots JM; Molist N; Boada A; Bayona C; Bjerrum L
Atencion primaria / Sociedad Espanola de Medicina de Familia y Comunitaria; 2006 Sep 30; 38(5); 307-8; author reply 308-9
Llibre Avances en hipertensión. Presión arterial sistólica, presión de pulso y riesgo cardiovascular
Coca A y Sierra C Editorial Juste. Barcelona, 2006. (Depósito Legal: B-1487-2006)
52
Enfermedad cardiovascular en el paciente con hipertensión arterial. El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial
Gil A, Coca A (Ed.) Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)
Eventos Cerebrovasculares e Hipertensión Arterial. ¿Qué hemos aprendido del estudio MOSES?
Coca A Editorial Grupo Ars XXI de Comunicación. Barcelona, 2006. (ISBN 84-9751-190-5 Depósito Legal: M-7940-2006)
Hipertensión arterial en Atención Primaria. Evidencia y práctica clínica.
De la Figuera M, Diogène E, Brotons C (eds) 2ª Edición, Barcelona, Euromedice, 2006. ISBN: 84-934482-9-X (obra completa). 84-96727-00-9 (Volumen I)
Manual de monitorización ambulatoria de la presión arterial y técnicas afines
Coca A, Mion D, Pickering T, Ramos F Editorial Médica A.W.W.E. S.L. Madrid, 2006. (ISBN 950-762-318-3. Depósito legal: M-50229-2006)
Capítol llibre Causas de mal cumplimiento del tratamiento
De la Figuera M En Suárez C (coord). Prevención de la progresión de la enfermedad cardiovascular. Importancia del cumplimiento terapéutico. Farmacia Comunicación SL. Madrid 2006; 27-39
Clasificación y fisiopatología del ictus, consecuencias y secuelas
Armario P, de la Figuera M En El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores SA. Madrid 2006: 271-77
Epidemiologia y factores de riesgo para el ictus.
Armario P, de la Figuera M En El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores SA. Madrid 2006: 261-70
La hipertensión arterial en el síndrome metabólico
Coca A, Sierra C HTA y síndrome metabólico. Acción Médica grupo. Madrid, 2006. (Depósito legal: M-52.180-2006)
Patologia infecciosa del tracte respiratori baix
Bonet Monne S., Casals Font A., Cots Yago JM., Falco Ferrer V.,Gonzalez Saavedra MI., Hospital Guardiola I., Luque Alonso A.,Pahissa Berga A., Pericas Bosch J., Serrano de Marco MT.,Simonet Aineto PJ., Van Esso Arbolave D
Guies de practica clinica i material docent, num. 11. Barcelona: Institut Catala de la Salut, 2006
Presión arterial. Tratamiento antihipertensivo y riesgo cardiovascular. Enfermedad cardiovascular en el paciente con hipertensión arterial.
Sierra C, Coca A El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)
Prevención del ictus con el tratamiento antihipertensivo.
Coca A, de la Figuera M En El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores SA. Madrid 2006: 323-35
Prevención del ictus con el tratamiento antihipertensivo. Enfermedad cardiovascular en el paciente con hipertensión arterial
Coca A, de la Figuera M El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)
Prevención primaria del ictus con el tratamiento antihipertensivo. Conclusiones y recomendaciones
Coca A, Sierra C El estudio LIFE. Contribución a la práctica clínica en hipertensión arterial. Jarpyo Editores. Madrid, 2006. (Depósito Legal: M-42443-2006)
Respiratorio y atención primaria Torres A, Naberán K Depósito legal : B-950-06 JC Ediciones Médicas, S.L.. Barcelona (España), Vol 1:1, 2006
53
Oncologia Clínica
Oncologia Clínica - Publicacions 2006 Titol Autors Cita Originals Activation of nuclear factor-kappa B is linked to resistance to eoadjuvant chemotherapy in breast cancer patients
Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, Campas C, Suarez M, Fabregat X, Campo E, Gascón P, Serrano S, Fernández PL, Rovira A, Albanell J
Endocr Relat Cancer 13: 607-616, 2006
Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-[alpha] in patients with metastatic melanoma
González-Cao M, Malvehy, J, Marti, R, Conill C, Sanchez M, Martin M, Carrera C, Herrero J, Gascon P, Mellado B, Castel T, Puig S
Melanoma Research 16(1):59-64, 2006
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
Codony J, Tapia M, Bosch M, Oliva C, Domingo-Domènech J, Mellado B, Rolfe M, Ross J, Gascón P, Rovira A, Albanell J
Mol Cancer Ther 5: 665-675, 2006
Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY
Birgegard G, Gascón P, Ludwig H. Eur J Haematol 77(5):378-86, 2006
Independent Risk Factors For Anemia In Cancer Patients Receiving Chemotherapy: Results From The European Cancer Anaemia Survey (ECAS)
Barrett-Lee P, Ludwig H, Birgegård G, Bokemeyer C, Gascon P, et al
Oncology 70: 34-48, 2006
Inhibitors of angiogenesis Almendro V, Gascón P Clin Transl Oncol 8: 475-481, 2006 Interleukin 6, a Nuclear Factor-KBTarget, Predicts resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-KB Inhibition by PS-1145 Enhances Docetaxel AntitumorActivity.
J Domingo-Domenech,C Oliva, A Rovira, J Codony-Servat, M Bosch, X Filella, C Montagut, M Tapia, C Campa, L Dang, M Rolfe, JS Ross, P Gascon, J Albanell, and B Mellado
Clin Cancer Res 12: 5578-5586, 2006
Molecular biology of renal cell carcinoma
Mellado B, Gascón P Clin Transl Oncol 10: 706-710, 2006
Molecular biology of renal cell carcinoma.
Mellado B; Gascon P Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico; 2006 Oct; 8(10); p. 706-10
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Maurel J, Martin-Richard M, Conill C, Sanchez M, Petriz L, Gines A, Miquel R, Gallego R, Cajal R, Ayuso C, Navarro S, Marmol M, Nadal C, Auge JM, Fernández-Cruz L, Gascón P
Int J Radiat Oncol Biol Phys 66: *1391-1398, 2006
Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy
Grau JJ, Palmero R, Marmol M, Domingo-Domènech J, Monzó M, Fuster J, Vidal O, Fondevila C, Garcia-Valdecasas JC
World J Surg Oncol 4: 53-61, 2006
Carta
54
Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY
Birgegard G; Gascon P; Ludwig H European journal of haematology; 2006 Nov; 77(5); p. 378-86
Oncologia Clínica - Projectes de recerca finançats 2006 Investigador Principal Referència Ajut Entitat Nom Projecte Import Durada
Gascon P FISS PI041353 Ministerio de Sanidad y Consumo
Efecto del microambiente medular en la integración de las células de cáncer de mama en la metástasis ósea: Papel del gen PPT-I y del factor TGF-b
59.800 2005-2008
Semiologia General
Semiologia General - Publicacions 2006 Títol Autors Cita Original Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis
Cid MC; Hoffman MP; Hernandez-Rodriguez J; Segarra M; Elkin M; Sanchez M; Vilardell C; Garcia-Martinez A; Pla-Campo M; Grau JM; Kleinman HK
Rheumatology (Oxford, England); 2006 Nov; 45(11); p. 1356
Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases
Ramos-Casals M; Nardi N; Brito-Zeron P; Aguilo S; Gil V; Delgado G; Bove A; Font J
Seminars in arthritis and rheumatism; 2006 Apr; 35(5); p. 312-21
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome
Ramos-Casals M; Sanchez-Tapias JM; Pares A; Forns X; Brito-Zeron P; Nardi N; Vazquez P; Velez D; Arias I; Bove A; Plaza J; Rodes J; Font J
The Journal of rheumatology; 2006 Aug; 33(8); p. 1593-9
Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption.
Zamora-Ros R; Urpi-Sarda M; Lamuela-Raventos RM; Estruch R; Vazquez-Agell M; Serrano-Martinez M; Jaeger W; Andres-Lacueva C
Clinical chemistry; 2006 Jul; 52(7); p. 1373
Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.
Estruch R; Martinez-Gonzalez MA; Corella D; Salas-Salvado J; Ruiz-Gutierrez V; Covas MI; Fiol M; Gomez-Gracia E; Lopez-Sabater MC; Vinyoles E; Aros F; Conde M; Lahoz C; Lapetra J; Saez G; Ros E
Annals of internal medicine; 2006 Jul 4; 145(1); p. 1
Evidence of apoptosis in alcoholic cardiomyopathy.
Fernandez-Sola J; Fatjo F; Sacanella E; Estruch R; Bosch X; Urbano-Marquez A; Nicolas JM
Human pathology; 2006 Aug; 37(8); p. 1100-10
Increased levels of atherosclerosis markers in salt-sensitive hypertension.
Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A;
American journal of hypertension : journal of the American Society of Hypertension; 2006 Jan; 19(1); p. 87-93
Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients
Bosch X; Guilabert A; Pallares L; Cerveral R; Ramos-Casals M; Bove A; Ingelmo M; Font J
Lupus; 2006; 15(9); p. 584-9
Longitudinal study on mitochondrial effects of didanosine-tenofovir combination
Lopez S; Negredo E; Garrabou G; Puig J; Ruiz L; Sanjurjo E; Ramos X; Infante AB; Casademont J; Cardellach F; Clotet B; Miro O
AIDS research and human retroviruses; 2006 Jan; 22(1); p. 33-9
Main training in medical specialties: a challenge of the present for a better health system
Teres J; Capdevila JA; Nonell F; Cardellach F; Bundo M; Torres M
Medicina clinica; 2006 Jun 24; 127(4); p. 139-44
55
Predictors of adverse outcome among patients with hypertension and coronary artery disease
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
Journal of the American College of Cardiology; 2006 Feb 7; 47(3); p. 547-51
Relation of left ventricular hypertrophy to regional cerebral blood flow: single photon emission computed tomography abnormalities in essential hypertension
Sierra C, de la Sierra A, Lomeña F, Paré JC, Larrousse M, Coca A
The Journal of Clinical Hypertension 2006; 8(10):700-705
Scientific evidence of interventions using the Mediterranean diet: a systematic review.
Serra-Majem L; Roman B; Estruch R Nutrition reviews; 2006 Feb; 64(2 Pt 2); p. S27-47
Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.
Miro O; Garrabou G; Lopez S; Deig E; Vidal I; Infante AB; Cardellach F; Casademont J; Pedrol E
Antiviral therapy; 2006; 11(5); p. 625-30
Total polyphenol intake estimated by a modified Folin-Ciocalteu assay of urine
Roura E; Andres-Lacueva C; Estruch R; Lamuela-Raventos RM
Clinical chemistry; 2006 Apr; 52(4); p. 749
Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients
Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zeron P; Bove A; Delgado G; Cervera R; Ingelmo M; Font J
Medicine; 2006 Mar; 85(2); p. 95-104
Revisió ¿Cuál es la presión idónea en el hipertenso de alto riesgo?
Coca A, Sierra C Jano 2006; 1597: 47-50
White matter lesions and cognitive impairment as silent cerebral disease in hypertension
Sierra C, Coca A Scientific World Journal 2006; 6: 494-501
Cas Clínic Sustained spontaneous clinical remission in giant cell arteritis: report of two cases with long-term followup
Hernandez-Rodriguez J; Garcia-Martinez A; Espigol-Frigole G; Grau JM; Collado A; Cid MC
Arthritis and rheumatism; 2006 Feb 15; 55(1); p. 160-2
Editorial Towards the best physician for the community
Cardellach F; Vilardell M Medicina clinica; 2006 Jun 24; 127(4); p. 136-8
Carta Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia
Garrabou G; Sanjurjo E; Miro O; Martinez E; Infante AB; Lopez S; Cardellach F; Gatell JM; Casademont J
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; 2006 Feb 15; 42(4); p. 584-5
Stimulatory autoantibodies to the PDGF receptor in scleroderma
Lozano E; Segarra M; Cid MC The New England journal of medicine; 2006 Sep 21; 355(12); p. 1278
Semiologia General - Projectes de recerca finançats -2006 Investigador
Principal Referència
Ajut Entitat Nom Projecte Import Durada
Cardellach F PI041239 Fondo de Investigación Sanitaria
Intoxicación por monóxido de carbono: tratamiento con oxigeno normobarico o hiperbarico y su correlación con la actividad del complejo IV mitocondrial y el grado de peroxidación lipidica de linfocitos de sangre periferica
94.990 2005-2007
56
Casademont J Red-G003/11 022681 Ordre: 015
MSCO – Ministerio de Sanidad y Consumo
Estudio clínico-epidemiológico y molecular de las enfermedades de la cadena respiratoria mitocondrial en España
20.147,65 2004-2006
Cid MC SAF2005-06250
Ministerio de Educación y Ciencia
Factores relacionados con el mantenimiento de la inflamación y la oclusión vascular. Implicaciones en la evolución clínica de los pacientes con arteritis de células gigantes
140.420 2005-2008
Cid MC SAF2005-06250
Ministerio de Educación y Ciencia
Factores relacionados con el mantenimiento de la inflamación y la oclusión vascular. Implicaciones en la evolución clínica de los pacientese con arteritis de células gigantes
140.420 2005-2008
Estruch R PI051519
FIS Efectos de la dieta mediterrànea en la prevención de la enfermedad cardiovascular
70.329 2006
Estruch R AGL2006-14228-C03-01/ALI
MEC Balance beneficio/riesgo del contenido de polifenoles y alcohol del vino
32.000 2006-2008
Estruch R AGL2004-08378-C02-02
MEC Biodisponibilidad de los fenoles del cacao: Bases científicas de la interacción de los fenoles y los marcadores inflamatorios de la arteriosclerosis
115.000 2005-2007
Estruch R PI041837 FIS Mecanismos básicos de los efectos de la dieta mediterránea sobre la enfermedad cardiovascular
84.525 2004-2006
Fernandez Sola J Fundación Privada MAPFRE-Medicina
Evaluación de parámetros de calidad de vida y recuperación funcional de pacientes con fatiga crónica en los diveros estadíos de la enfermedad.
9.000 Febrero 2005-Marzo 2006
Grau JM 2005SGR00300 Agencia de Gestió d´Ajuts Universitaris i de Recerca
Grup de Recerca Múscular 35.600 2005-2007
Grau JM PI04464 Fondo de Investigación Sanitario
Angiogénesis y citocinas como factores pronósticos en la dermatomiositis. Caracterización del síndrome antisintetasa
31.050 2005-2007
Grau JM FIS PI040464 FIS Angiogénesis y citocinas como factores pronósticos en la dermatomiositis. Caracterización del síndrome antisintetasa
31.050 2004-2006
Nicolas JM PI050164 FIS Marcadores biológicos del fracaso multiorgánico en el shock séptico 60.000 2005-2008
Hospitals Col·laboradors
Publicacions Hospitals Col·laboradors Títol Autors Cita Original Automedida de la presión arterial domiciliaria. Influencia del sistema de cáculo de la media en el diagnóstico de la Hipertensión de bata blanca
J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX Naberan, A. Botey
Aten Primaria 2006;38:212-8
Cardiovascular risk factors in patients aged 85 or older with ischemic stroke
Arboix A; Miguel M; Ciscar E; Garcia-Eroles L; Massons J; Balcells M
Clinical neurology and neurosurgery; 2006 Oct; 108(7); p. 638-43
Clinical implications of headache in lacunar stroke: relevance of site of infarct
Arboix A; Grau-Olivares M; Garcia-Eroles L; Massons J; Comes E; Targa C
Headache; 2006 Jul-Aug; 46(7); p. 1172-80
Clinical study of 39 patients with atypical lacunar syndrome
Arboix A; Lopez-Grau M; Casasnovas C; Garcia-Eroles L; Massons J; Balcells M
Journal of neurology, neurosurgery, and psychiatry; 2006 Mar; 77(3); p. 381-4
Clustering of cardiovascular risk factors and prevalence of metabolic syndrome in subjects with resistant hypertension
Hernandez del Rey R; Armario P; Martin-Baranera M; Castellanos P
Medicina clinica; 2006 Jul 15; 127(7); p. 241-5
Determinants of early outcome in spontaneous lobar cerebral hemorrhage
Arboix, Manzano C, García-Eroles L, Massons J, Oliveres M, Parra O, Targa C
Acta Neurol Scand 2006; 114:187-92
57
Differences in the etiology of community-acquired penumonia according to site of care: A population-based study
Almirall J. Et al. GEMPAC Study Group (... O. Parra...)
Respiratory Medicine 2007; 101:2168-75
Home blood presure self-monitoing: diagnostic performance in white-coat hypertension
J. Bayó, FX Cos, C. Roca, A. Dalfó, MM Martín-Baranera, A. Botey
Blood Presure Monitoring 2006; 11:47-52
Impact of female gender on prognosis in type 2 diabetic patients with ischemic stroke
Arboix A; Milian M; Oliveres M; Garcia-Eroles L; Massons J
European neurology; 2006; 56(1); p. 6
NARP-MILS syndrome caused by 8993 T > G mitochondrial DNA mutation: a clinical, genetic and neuropathological study
Rojo A; Campos Y; Sanchez JM; Bonaventura I; Aguilar M; Garcia A; Gonzalez L; Rey MJ; Arenas J; Olive M; Ferrer I
Acta neuropathologica; 2006 Jun; 111(6); p. 610-6
Prevalence of hypertension in elderly long-term care residents in Spain. The Geriatric HTA study
Martin-Baranera M; Sanchez Ferrin P; Armario P Medicina clinica; 2006 Nov 11; 127(18); p. 681-7
Prognostic value of headache in cardioembolic stroke
Arboix A Medicina clinica; 2006 Jun 3; 127(1); p. 5-7
Quilotorax y ascitis quilosa. Manifestación inicial de un Síndrome Nefrótico
Bonnin. M, Pelegrí A, Parra O Med Clin 2006; 127:718
Rendiment diagnòstic de l’automesura se la pressió arterial domiciliària en la Hipertensió Clínica Aïllada
J. Bayó, C. Roca, A. Dalfó, MM Martín-Baranera, C. Medrano
Butlletí de la Societat Catalana de Medicina Familiar i Comunitària 2006; 24:14-20
Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease
Almagro P; Barreiro B; Ochoa de Echaguen A; Quintana S; Rodriguez Carballeira M; Heredia JL; Garau J
Respiration; international review of thoracic diseases; 2006; 73(3); p. 311
Revisió Efermedades importadas en inmigrantes: mito y realidad
C. Roca, X. Balanzó An Sist Sanit Nav 2006; 29 (supl 1):139-44
Hepatitis B en situaciones especiales
Torres M Gastroenterologia y Hepatologia 2006; 29(supl 2):16-81
Nocturnal hypoxia is associated with silent cerebrovascular disease: An original approach
Parra O Am J Hypertens. 2006 Aug;19(8):876-7
Cas Clínic Tuberculosis, ancylostomiasis and eosinophilic pleural effusion
Rodriguez E; Delgado Y; Buges J; Bastida T; Torres M
Anales de medicina interna (Madrid, Spain : 1984); 2006 Jan; 23(1); p. 46-7
Lllibre Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición)
Arboix A Ed. Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X M-10959-2006
Capítol llibre Colitis colágena y linfocítica Fernández-Bañares F, Viver JM En: Tratamiento de las enfermedades
gastroenterológicas. Ponce J ed. Ediciones Doyma S.L. Barcelona, 2006; Capítulo 32, p. 295-300
Ecocardiografía Alió J, Ruiz-Majoral A, Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
58
Electrocardiograma Arboix A, Martorell E, Alió J En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Examen físico general Arboix A, Martí-Vilalta JL En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Historia Clínica Martí-Vilalta Jl, Martí-Fàbregas J, Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Ictus: tipos etiológicos y criterios diagnóstico
Arboix A, Díaz J, Pérez-Sempere A, Alvarez-Sabín J En: Guía para el diagnóstico y tratamiento del ictus. Guías oficiales de la Sociedad Española de Neurología. Ed. Prous Science SA, Barcelona. 2006.ISBN: 84-8124-225-X
Métodos diagnósticos en el infarto cerebra
Arboix A, Dávalos A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Métodos diagnósticos en el infarto migrañoso
Massons J, Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Polisomnografía Parra O En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición). Arboix A (ed). Ed.Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Presentación Arboix A En: Métodos diagnósticos en las enfermedades vasculares cerebrales (2 edición) Arboix A (ed). Ed. Ergon ed, Madrid. 2006. ISBN: 84-8473-451-X
Profilaxis primaria y secundaria de la hepatitis B
Torres M En: Planas Vilà R, Solà Lamoglia R, eds. Hepatitis B. Manual para Atención Primaria. Barcelona: Mayo Ediciones, 2006. ISBN84-96537-30-7
Trastornos de la respiración durante el sueño y accidente vascular cerebral
Parra O, Arboix A En: Santamaria J ed. Continua Neurológica. Trastornos del sueño. Barcelona. Grupo ARS XXI de Comunicación 2006. ISBN 849751237.
Hospitals col·laboradors - Projectes de recerca finançats 2006 Investigador
Principal Referència
Ajut Entitat Nom Projecte Import Durada
Torres M PI03/1131 Instituto de Investigación Carlos III
Accidentes biológicos parenterales en el personal sanitario. Análisis de los factores prevenibles mediante precauciones estándar
3.450 2004-2006
59
Economia
60
61
Despeses Funcionament Ordinari 2006
Beca col·laboració 4.851,00 Biblioteca/Documentació 495,45 Correu/Missatgeria 554,83 Equipament Inventariable Secretaria 1.859,45 Fotografia 85,72 Funcionament 171,21 Habilitats Clíniques 25.340,00 Material Docent Inventariable 8.332,43 Material oficina/fotocòpies 5.740,99 Microscopia Electrònica 157,85 Reparacions 121,86 Software 433,49 Telèfon 449,29 Xarxa 400,80 Total assignació 2006 48.994,37
+
Despeses Funcionament Ordinari 2006 Habilitats Clíniques
Material Docent Inventariable
Material oficina/fotocòpies
Beca col·laboració
Equipament InventariableSecretariaCorreu/Missatgeria
Biblioteca/Documentació
Telèfon
Software
Xarxa
top related